Dental photocurable composition containing highly soluble photoacid generator
By using an iodonium salt-based photoacid generator and aliphatic tertiary amine compound formed with anion of logS of -4 or less in dental photocurable compositions, the poor physical properties of the photopolymerization initiator after low temperature storage are solved. The problem of this achieves excellent mechanical properties at room temperature.
Patent Information
- Application Number
- CN202110276469.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2021-03-12
- Filing Date
- 2021-03-15
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-03-15
AI Technical Summary
The existing dental photopolymerization initiators cannot fully restore their physical properties after low temperature storage, resulting in poor mechanical properties at room temperature.
Dental photocurable compositions including polymerizable monomers, photosensitizers, photoacid generators and photopolymerization accelerators are used, wherein the photoacid generator is an iodonium salt-based compound formed with an anion having a logS of -4 or less. , and use aliphatic tertiary amine compounds in photopolymerization accelerators.
After low-temperature storage, it still exhibits excellent mechanical and physical properties after returning to room temperature, which improves the storage stability and use performance of dental photocurable compositions.
Smart Images

Figure BDA0002976833620000321 
Figure BDA0002976833620000322 
Figure BDA0002976833620000323
Abstract
Description
Technical Field
[0001] The present invention relates to a photocurable composition for dental use. Background Art
[0002] In the dental field, dental photocurable compositions are used in oral treatments and are applied to dental adhesives, dental composite resins, dental abutment repair materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing adhesives, dental glass ionomer cements, dental cutting materials, dental 3D printing materials, and the like.
[0003] Japanese Patent No. 4093974 proposes a photopolymerization initiator containing a photoacid generator (triazine compound or specific aryliodonium salt), a sensitizer, and an electron donating compound.
[0004] Japanese Patent No. 4596786 proposes a photopolymerization initiator containing a photoacid generator (triazine compound or specific aryliodonium salt), a sensitizer, and an electron donating compound. Summary of the invention
[0005] However, dental photocurable compositions using conventional photopolymerization initiators described in Japanese Patent Nos. 4093974 and 4596786 cannot obtain sufficient physical properties after storage at low temperatures.
[0006] An object of the present invention is to provide a dental photocurable composition that can exhibit excellent mechanical properties even after returning from low temperature to room temperature.
[0007] The dental photocurable composition of the present invention comprises (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator, wherein the photoacid generator (C) comprises (C-1) an iodonium salt compound formed with an anion having a logS of -4 or less.
[0008] The dental photocurable composition of the present invention exhibits excellent mechanical properties even after returning to room temperature from low temperature. DETAILED DESCRIPTION
[0009] In the present invention, 0.5 parts by mass or more of an iodonium salt compound formed of (C-1) and an anion having a logS of -4 or less may be contained based on 100 parts by mass of the (A) polymerizable monomer.
[0010] In the present invention, the iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less may include an aryl iodonium salt having an anion containing an organic group and one or more atoms of P, B, Al, S, and Ga.
[0011] In the present invention, the iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less may include an aryl iodonium salt having an anion containing an organic group in which at least one H is substituted by F and one or more atoms of any one of P, B, Al, S, and Ga.
[0012] In the present invention, an aliphatic tertiary amine compound may be contained as (D) the photopolymerization accelerator.
[0013] In the present invention, (D) the photopolymerization accelerator may include (D-1) an aliphatic tertiary amine compound not having two or more primary hydroxyl groups.
[0014] In the present invention, the dental photocurable composition may be a single-component composition, which contains 0.005 to 0.5 parts by mass of (B) a photosensitizer, 0.5 to 10.0 parts by mass of (C) a photoacid generator, and 0.01 to 20 parts by mass of (D) a photopolymerization accelerator, based on 100 parts by mass of (A) a polymerizable monomer.
[0015] In the present invention, it can be a two-component photocurable composition, consisting of a first paste and a second paste, the ratio of the first paste to the second paste is 1:0.8~1.2, relative to the total 200 mass parts of (A) polymerizable monomers contained in the first paste and the second paste, 0.01~2.0 mass parts of (B) photosensitizer, 1.0~20 mass parts of (C) photoacid generator, and 0.02~40 mass parts of (D) photopolymerization accelerator.
[0016] Hereinafter, each component of the dental photocurable composition of the present invention is described in detail. The dental photocurable composition of the present invention is used as a dental adhesive material, a dental composite resin, a dental abutment repair material, a dental resin cement, a dental coating material, a dental pit and fissure sealing material, a dental cosmetic material, a dental loose tooth fixing adhesive material, a dental hard resin, a dental cutting material, and a dental 3D printing material.
[0017] In dental clinics, in order to restore the aesthetic and functional properties of missing teeth caused by caries or fractures, direct restoration with dental composite resins or indirect restoration of prosthetic devices made of ceramics or dental hard resins with dental resin cements is performed. In addition, dental adhesive materials for bonding dental composite resins to various dental materials and natural teeth, dental loose tooth fixing adhesive materials for fixing loose teeth, dental coating materials for protecting hypersensitive or formed vital pulp teeth from external stimulation or secondary caries, especially dental pit and fissure sealing materials for preventing caries by filling complex grooves such as deciduous teeth, dental cosmetic materials for temporarily restoring aesthetics by masking tooth discoloration, and dental abutment construction materials for forming abutment teeth when the crown of a tooth collapses due to caries are used. In recent years, composite materials such as dental cutting materials for making prosthetic devices by CAD / CAM processing and dental 3D printing materials for making prosthetic devices by 3D printing have been newly developed, and various dental materials are used for treatment. The above materials are mixed with a resin matrix composed of a plurality of polymerizable monomers, various fillers such as inorganic fillers, organic-inorganic composite fillers, and polymerization initiators according to their uses, and prepared into a uniform paste. For example, a part of the material is a dental filling composite resin filled in the teeth in the state of an uncured paste, and after being given the anatomical form of natural teeth by dental appliances such as instruments, it is cured by irradiating light with a dental light irradiator. The irradiation light from the light irradiator is generally about 360 to 500 nm in wavelength and has an intensity of 100 to 2000 mW / cm 2 On the other hand, dental resin cement is used to bond prosthetic devices to pits and fissures or abutment teeth, and after the prosthetic devices are installed on the pits and fissures or abutment teeth, they are irradiated with light to be cured.
[0018] As photopolymerization initiators for such dental materials, photosensitizers and systems in which appropriate photopolymerization accelerators are combined in the photosensitizers are widely used. As photosensitizers, acylphosphine oxide compounds and α-diketone compounds are known, and in particular, α-diketone compounds have polymerization initiation capabilities in the visible light wavelength region that has little effect on the human body. In addition, as polymerization accelerators combined with photosensitizers, tertiary amine compounds are well known. The combination of α-diketone compounds and tertiary amine compounds has high polymerization activity to irradiated light, and is therefore used in the field of dental materials. The dental photocurable composition containing the photopolymerization initiator exhibits excellent mechanical properties such as hardness, bending strength, and compression strength required by various materials.
[0019] However, when the combination of the α-diketone compound and the tertiary amine compound is used as a photopolymerization initiator, the problem of lack of stability under ambient light arises. That is, the operator performs the operation under white light (ambient light) such as a dental lamp or an indoor light such as a fluorescent lamp that irradiates the oral cavity. When only the combination of the α-diketone compound and the tertiary amine compound is used as a photopolymerization initiator, the operator shows high sensitivity not only to the irradiated light but also to the ambient light. Therefore, in operations such as filling, surfacing, and installation, there are problems such as slow curing, increased viscosity of the paste, and difficulty in operation.
[0020] In order to solve the above-mentioned problems, a photopolymerization initiator comprising an aryliodonium salt as a photoacid generator, a sensitizer, and an electron donor compound has been proposed. However, there is a problem in solubility in dental photocurable compositions. Since precipitation occurs during storage at low temperatures, when the dental photocurable composition is used after being transported to a cold region, there is a case where sufficient physical properties are not exhibited.
[0021] The present inventors have found that the dental photocurable composition of the present invention does not precipitate when stored at low temperatures using a photoacid generator with high fat solubility, and exhibits excellent physical properties, thereby completing the present invention. More specifically, it has been found that the fat solubility of the anion of the aryl iodonium salt has a significant effect on the solubility of the polymerizable monomer. It has been found that the dental photocurable composition containing an aryl iodonium salt formed with an anion having a specific logS (Log Solubility) value is stable even under refrigerated or frozen storage conditions, and logS is a measure of water solubility that is a property opposite to fat solubility obtained by calculation, thereby completing the present invention.
[0022] [(A) Polymerizable Monomer]
[0023] As long as the (A) polymerizable monomer of the present invention is a known substance, it can be used without restriction. Among the polymerizable monomers or compounds having polymerizable groups described in the present invention, it is preferred that the polymerizable group is a group that exhibits free radical polymerizability. Specifically, from the viewpoint of easy free radical polymerization, the polymerizable group is preferably a (meth) acrylic acid group and / or a (meth) acrylamide group. It should be noted that in this specification, "(meth) acrylic acid group" refers to acrylic acid group and / or methacrylic acid group, "(meth) acryloyl group" refers to acryloyl group and / or methacryloyl group, "(meth) acrylate" refers to acrylate and / or methacrylate, and "(meth) acrylamide" refers to acrylamide and / or methacrylamide. It is also possible to preferably use a polymerizable monomer having a substituent at the α position of an acrylic acid group and / or an acrylamide group. There are compounds having one free radical polymerizable group, compounds having two free radical polymerizable groups, compounds having three or more free radical polymerizable groups, compounds having an acidic group, compounds having an alkoxysilyl group, a sulfur atom, and the like.
[0024] Specific examples of the polymerizable monomer having one radical polymerizable group and no acidic group include 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, 6-hydroxyhexyl (meth)acrylate, 10-hydroxydecyl (meth)acrylate, propylene glycol mono (meth)acrylate, glycerol mono (meth)acrylate, erythritol mono (meth)acrylate, N-hydroxymethyl (meth)acrylamide. , N-hydroxyethyl (meth)acrylamide, N,N-(dihydroxyethyl) (meth)acrylamide, methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, isobutyl (meth)acrylate, benzyl (meth)acrylate, lauryl (meth)acrylate, 2,3-dibromopropyl (meth)acrylate, 3-(meth)acryloxypropyltrimethoxysilane, 11-(meth)acryloxyundecyltrimethoxysilane, (meth)acrylamide, etc.
[0025] Specific examples of the polymerizable monomer having two free radical polymerizable groups and no acidic group include 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-(meth)acryloyloxy)-2-hydroxypropoxyphenyl]propane (commonly referred to as "Bis-GMA"), 2,2-bis(4-(meth)acryloyloxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxy)-2-hydroxypropoxyphenyl)propane, and 2,2-bis(4-(meth)acryloyloxy)-2-hydroxypropoxyphenyl)propane. acryloyloxytetraethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydipropoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxydiethoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxyditriethoxyphenyl)propane, 2-(4-(meth)acryloyloxydipropoxyphenyl)-2-(4-(meth)acryloyloxy triethoxyphenyl)propane, 2,2-bis(4-(meth)acryloxypropoxyphenyl)propane, 2,2-bis(4-(meth)acryloxyisopropoxyphenyl)propane, 1,4-bis(2-(meth)acryloxyethyl)pyromellitic acid ester, glycerol di(meth)acrylate, 1-(acryloxy)-3-(methacryloxy)-2-propanol, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butanediol di(meth)acrylate, Neopentyl glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)dimethacrylate (commonly known as "UDMA"), 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, and the like.
[0026] Specific examples of the polymerizable monomer having three or more free radical polymerizable groups and having no acidic group include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetramethacrylate, and 1,7-diacryloyloxy-2,2,6,6-tetraacryloyloxymethyl-4-oxyheptane.
[0027] The polymerizable monomer having an acidic group can be used without limitation as long as it has one or more polymerizable groups and at least one or more acidic groups such as a phosphate group, a pyrophosphate group, a thiophosphate group, a phosphonic acid group, a sulfonic acid group, or a carboxylic acid group.
[0028] Specific examples of the polymerizable monomer having a phosphate group include 2-(meth)acryloyloxyethyl dihydrogen phosphate, 3-(meth)acryloyloxypropyl dihydrogen phosphate, 4-(meth)acryloyloxybutyl dihydrogen phosphate, 5-(meth)acryloyloxypentyl dihydrogen phosphate, 6-(meth)acryloyloxyhexyl dihydrogen phosphate, 7-(meth)acryloyloxyheptyl dihydrogen phosphate, 8-(meth)acryloyloxyoctyl dihydrogen phosphate, 9-(meth)acryloyloxynonyl dihydrogen phosphate, 10-(meth)acryloyloxydecyl dihydrogen phosphate, 11-(meth)acryloyloxyundecyl dihydrogen phosphate, 12-(meth)acryloyloxydodecyl dihydrogen phosphate, 16-(meth)acryloyloxyhexadecyl dihydrogen phosphate, 20-(meth)acryloyloxyeicosyl dihydrogen phosphate, bis[2-(meth)acryloyloxyethyl] hydrogen phosphate, bis[4-(meth)acryloyloxybutyl] hydrogen phosphate, bis[6-(meth)acryloyloxyhexyl] hydrogen phosphate, bis[8-(meth)acryloyloxyoctyl] hydrogen phosphate, bis[9-(meth)acryloyloxynonyl] hydrogen phosphate, bis[10-(meth)acryloyloxydecyl] hydrogen phosphate, 1,3-bis(meth)acryloyloxypropyl dihydrogen phosphate, 2-(meth)acryloyloxyethylphenyl hydrogen phosphate, 2-(meth)acryloyloxyethyl-2-bromoethyl hydrogen phosphate, bis[2-(meth)acryloyloxy-(1-hydroxymethyl)ethyl] hydrogen phosphate; acyl chlorides, alkali metal salts, ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds.
[0029] Specific examples of polymerizable monomers having a pyrophosphate group include bis[2-(meth)acryloyloxyethyl] pyrophosphate, bis[4-(meth)acryloyloxybutyl] pyrophosphate, bis[6-(meth)acryloyloxyhexyl] pyrophosphate, bis[8-(meth)acryloyloxyoctyl] pyrophosphate, bis[10-(meth)acryloyloxydecyl] pyrophosphate; acid chlorides, alkali metal salts, ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds.
[0030] Specific examples of polymerizable monomers having a thiophosphoric acid group include 2-(meth)acryloyloxyethyl dihydrogen thiophosphoric acid ester, 3-(meth)acryloyloxypropyl dihydrogen thiophosphoric acid ester, 4-(meth)acryloyloxybutyl dihydrogen thiophosphoric acid ester, 5-(meth)acryloyloxypentyl dihydrogen thiophosphoric acid ester, 6-(meth)acryloyloxyhexyl dihydrogen thiophosphoric acid ester, 7-(meth)acryloyloxyheptyl dihydrogen thiophosphoric acid ester, 8-(meth)acryloyloxyoctyl dihydrogen thiophosphoric acid ester, 9-(meth)acryloyloxybutyl dihydrogen thiophosphoric acid ester, Oxynonyl dihydrogen thiophosphate, 10-(meth)acryloyloxydecyl dihydrogen thiophosphate, 11-(meth)acryloyloxyundecyl dihydrogen thiophosphate, 12-(meth)acryloyloxydodecyl dihydrogen thiophosphate, 16-(meth)acryloyloxyhexadecyl dihydrogen thiophosphate, 20-(meth)acryloyloxyeicosyl dihydrogen thiophosphate; acyl chlorides, alkali metal salts, ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds. It should be noted that the polymerizable monomer having a thiophosphate group can also be classified as a polymerizable monomer having a sulfur atom.
[0031] Specific examples of polymerizable monomers having a phosphonic acid group include 2-(meth)acryloyloxyethylphenylphosphonate, 5-(meth)acryloyloxypentyl-3-phosphonopropionate, 6-(meth)acryloyloxyhexyl-3-phosphonopropionate, 10-(meth)acryloyloxydecyl-3-phosphonopropionate, 6-(meth)acryloyloxyhexyl-3-phosphonoacetate, and 10-(meth)acryloyloxydecyl-3-phosphonoacetate; acid chlorides, alkali metal salts, and ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are substituted with amide bonds.
[0032] Specific examples of the polymerizable monomer having a sulfonic acid group include 2-(meth)acrylamide-2-methylpropanesulfonic acid and 2-sulfoethyl (meth)acrylate.
[0033] The polymerizable monomer having a carboxylic acid group is classified into a (meth)acrylic compound having one carboxyl group in the molecule and a (meth)acrylic compound having a plurality of carboxyl groups in the molecule. Specific examples of the (meth)acrylic compound having one carboxyl group in the molecule include (meth)acrylic acid, N-(meth)acryloylglycine, N-(meth)acryloylaspartic acid, O-(meth)acryloyltyrosine, N-(meth)acryloyltyrosine, N-(meth)acryloylphenylalanine, N-(meth)acryloyl-p-aminobenzoic acid, N-(meth)acryloyl-o-aminobenzoic acid, p-vinylbenzoic acid, 2-(meth)acryloyloxybenzoic acid. , 3-(meth)acryloxybenzoic acid, 4-(meth)acryloxybenzoic acid, N-(meth)acryloxy-5-aminosalicylic acid, N-(meth)acryloxy-4-aminosalicylic acid, 2-(meth)acryloxyethyl hydrogen succinate, 2-(meth)acryloxyethyl hydrogen phthalate, 2-(meth)acryloxyethyl hydrogen malate; acyl halides of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds, etc. Specific examples of the (meth)acrylic acid compound having a plurality of carboxyl groups in the molecule include 6-(meth)acryloyloxyhexane-1,1-dicarboxylic acid, 9-(meth)acryloyloxynonane-1,1-dicarboxylic acid, 10-(meth)acryloyloxydecane-1,1-dicarboxylic acid, 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, 12-(meth)acryloyloxydodecane-1,1-dicarboxylic acid, 13-(meth)acryloyloxytridecane-1,1-dicarboxylic acid, 4-(Meth)acryloyloxyethyl trimellitate, 4-(meth)acryloyloxybutyl trimellitate, 4-(meth)acryloyloxyhexyl trimellitate, 4-(meth)acryloyloxydecyl trimellitate, 2-(meth)acryloyloxyethyl-3'-(meth)acryloyloxy-2'-(3,4-dicarboxybenzoyloxy)propyl succinate; acid anhydrides and acid halides of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds, etc.
[0034] Specific examples of the polymerizable monomer having an alkoxysilyl group include a (meth)acrylic compound having one alkoxysilyl group in the molecule and a (meth)acrylic compound having a plurality of alkoxysilyl groups in the molecule. Examples thereof include 2-(meth)acryloxyethyltrimethoxysilane, 3-(meth)acryloxypropyltrimethoxysilane, 3-(meth)acryloxypropyltriethoxysilane, 3-(meth)acryloxypropylmethyldimethoxysilane, 4-(meth)acryloxybutyltrimethoxysilane, 5-(meth)acryloxypentyltrimethoxysilane, 6-(meth)acryloxyhexyltrimethoxysilane, 7-(meth)acryloxyheptyltrimethoxysilane, 8-(meth)acryloxyoctyltrimethoxysilane, 9-(meth)acryloxynonyltrimethoxysilane, 10-(meth)acryloxydecyltrimethoxysilane, and 11-(meth)acryloxyundecyltrimethoxysilane.
[0035] As long as the polymerizable monomer having a sulfur atom is a polymerizable monomer having one or more sulfur atoms and a polymerizable group, a known compound can be used without any limitation. Specifically, it refers to a compound having a partial structure such as -SH, -SS-, >C=S, >CSC<, >P=S, or a compound having the above structure by tautomerism. As specific examples, 10-methacryloyloxydecyl-6,8-dithiooctanoate, 6-methacryloyloxyhexyl-6,8-dithiooctanoate, 6-methacryloyloxyhexyl 2-thiouracil-5-carboxylate, 2-(11-methacryloyloxyundecylthio)-5-mercapto-1,3,4-thiadiazole, and 10-(meth)acryloyloxydecyl dihydrogen thiophosphate can be cited.
[0036] In addition to these polymerizable monomers, there is no restriction even if an oligomer or prepolymer having at least one polymerizable group is used in the molecule. In addition, there is no problem even if a substituent such as a fluoro group is present in the same molecule. The polymerizable monomers described above can be used alone or in combination.
[0037] The dental photocurable composition of the present invention may contain a known polymerizable monomer containing an acidic group as (A) a polymerizable monomer to impart adhesion to tooth structure and prosthetic devices. Preferably, it is 10-methacryloyloxydecyl dihydrogen phosphate or 6-methacryloyloxyhexyl phosphonoacetate. From the viewpoint of imparting adhesion, the amount of the polymerizable monomer containing an acidic group is 1 part by mass or more, more preferably 10 parts by mass or more, relative to 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
[0038] In the dental photocurable composition of the present invention, in order to impart adhesion to glass ceramics, a silane coupling agent can be contained as (A) polymerizable monomer. As long as it is a known silane coupling agent, it can be used without restriction, but preferably 3-methacryloxypropyltrimethoxysilane, 8-methacryloxyoctyltrimethoxysilane, 11-methacryloxyundecyltrimethoxysilane. From the viewpoint of imparting adhesion, relative to the total amount of 100 parts by mass of the polymerizable monomer in the composition, it is more than 1 part by mass, more preferably more than 10 parts by mass and less than 20 parts by mass. Since the purpose of the silane coupling agent as a polymerizable monomer is to impart adhesion to a resin material or the like of a filler comprising glass ceramics or composed of glass ceramics, it is necessary to separately match with the surface treatment agent of the filler.
[0039] In order to impart adhesion to precious metals, the dental photocurable composition of the present invention may contain a polymerizable monomer having a sulfur atom as the (A) polymerizable monomer. From the viewpoint of imparting adhesion, the amount of the polymerizable monomer having a sulfur atom is 0.01 parts by mass or more, more preferably 0.1 parts by mass or more and less than 10 parts by mass, relative to 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
[0040] <Photopolymerization initiator>
[0041] The photopolymerization initiator used in the dental photocurable composition of the present invention includes (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator, and these are not particularly limited, and commonly used known compounds can be used without any limitation.
[0042] [(B) Photosensitizer]
[0043] Specific examples of the (B) photosensitizer that can be used in the present invention include benzyl, camphorquinone, camphorquinone carboxylic acid, camphorquinone sulfonic acid, α-naphthyl, naphthyl acetone, p,p'-dimethoxybenzyl, p,p'-dichlorobenzyl acetyl, pentanedione, 1,2-phenanthrenequinone, 1,4-phenanthrenequinone, 3,4-phenanthrenequinone, 9,10-phenanthrenequinone, naphthoquinone and other α-diketones; benzoin, benzoin methyl ether, benzoin ethyl ether and other benzoin alkyl ethers; thioxanthones such as thioxanthone, 2-chlorothioxanthone, 2-methylthioxanthone, 2-isopropylthioxanthone, 2-methoxythioxanthone, 2-hydroxythioxanthone, 2,4-diethylthioxanthone, 2,4-diisopropylthioxanthone; benzophenones such as benzophenone, p-chlorobenzophenone, p-methoxybenzophenone;Bis(2,6-dimethoxybenzoyl)phenylphosphine oxide, bis(2,6-dimethoxybenzoyl)(2,4,4-trimethylpentyl)phosphine oxide, bis(2,6-dimethoxybenzoyl)-n-butylphosphine oxide, bis(2,6-dimethoxybenzoyl)-(2-methylprop-1-yl)phosphine oxide, bis(2,6-dimethoxybenzoyl)-(1-methylprop-1-yl)phosphine oxide, bis(2,6-dimethoxybenzoyl)-tert-butylphosphine oxide, bis(2,6-dimethoxybenzoyl)cyclohexylphosphine oxide, bis(2,6-dimethoxybenzoyl)octylphosphine oxide, bis(2-methoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2-methoxybenzoyl) bis(2,6-diethoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,6-diethoxybenzoyl)(1-methylprop-1-yl)phosphine oxide, bis(2,6-diethoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,6-dibutoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,4-dimethoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)(2,4-dipentyloxyphenyl)phosphine oxide, bis(2,6-dimethoxybenzoyl)benzylphosphine oxide, bis(2,6-dimethoxybenzoyl) Acylphosphine oxides such as bis(2,6-dimethoxybenzoyl)-2-phenylpropylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylethylphosphine oxide, bis(2,6-dimethoxybenzoyl)benzylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylpropylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylethylphosphine oxide, 2,6-dimethoxybenzoylbenzylbutylphosphine oxide, 2,6-dimethoxybenzoylbenzyloctylphosphine oxide, bis(2,4,6-trimethylbenzoyl)isobutylphosphine oxide and 2,6-dimethoxybenzoyl-2,4,6-trimethylbenzoyl-n-butylphosphine oxide, bisbenzoyldiethylgermanium, bisbenzoyldimethylgermanium ...bis(2,6-dimethoxybenzoyl)-2-phenylpropylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylethylphosphine oxide, 2,6-dimethoxybenzoylbenzylbutylphosphine oxide, 2,6-dimethoxybenzoyl Acylgermanium compounds such as benzoyldibutylgermanium, bis(4-methoxybenzoyl)dimethylgermanium and bis(4-methoxybenzoyl)diethylgermanium, α-aminoacetophenones such as 2-benzyl-dimethylamino-1-(4-morpholinylphenyl)-butanone-1, 2-benzyl-diethylamino-1-(4-morpholinylphenyl)-acetone-1, ketals such as benzyl dimethyl ketal, benzyl diethyl ketal, benzyl (2-methoxyethyl ketal), titanium ocenes such as bis(cyclopentadienyl)-bis〔2,6-difluoro-3-(1-pyrrolyl)phenyl〕-titanium, bis(cyclopentadienyl)-bis(pentafluorophenyl)-titanium, bis(cyclopentadienyl)-bis(2,3,5,6-tetrafluoro-4-dimethylsiloxyphenyl)-titanium, etc. ;
[0044] (B) photosensitizer can be appropriately selected according to the wavelength, intensity, light irradiation time, type or amount of other components combined for the light used for polymerization. In addition, photosensitizer can be used alone or in combination of two or more. Among them, it is preferred to use α-diketone compounds with maximum absorption wavelength in the visible light region, and more preferably camphorquinone compounds such as camphorquinone, camphorquinone carboxylic acid, camphorquinone sulfonic acid, and in particular, from the perspective of easy availability, camphorquinone is preferred.
[0045] Generally, the amount of (B) photosensitizer is preferably 0.005 to 1.0 parts by mass, more preferably 0.01 to 1.0 parts by mass, and further preferably 0.05 to 1.0 parts by mass, relative to 100 parts by mass of the total amount of (A) polymerizable monomers contained in the dental photocurable composition. When the amount of photosensitizer is less than 0.005 parts by mass, the polymerization activity to the irradiated light is lacking, and the curing is insufficient. When the amount is greater than 1.0 parts by mass, although sufficient curability is exhibited, the ambient light stability becomes shorter and the yellow tint increases.
[0046] [(C) Photoacid generator]
[0047] In the dental photocurable composition of the present invention, as (C) photoacid generator, an iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less can be included. In the dental photocurable composition of the present invention, an iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less and other known photoacid generators can be used without restriction. Specifically, triazine compounds, iodonium salt compounds, sulfonium salt compounds, sulfonate compounds, etc. can be cited. Among them, triazine compounds and iodonium salt compounds are preferred because of their high polymerizability when used in combination with a sensitizer. More preferably, iodonium salt compounds are used. Ionium salt compounds are easily sensitized by photosensitizers that absorb in the visible light region.
[0048] Specific examples of the triazine compound include 2,4,6-tris(trichloromethyl)-s-triazine, 2,4,6-tris(tribromomethyl)-s-triazine, 2-methyl-4,6-bis(trichloromethyl)-s-triazine, 2-methyl-4,6-bis(tribromomethyl)-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methylthiophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(tribromomethyl)-s-triazine, trichloromethyl)-s-triazine, 2-(2,4-dichlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-bromophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-tolyl)-4,6-bis(trichloromethyl)-s-triazine, 2-n-propyl-4,6-bis(trichloromethyl)-s-triazine, 2-(α,α,β-trichloroethyl)-4,6-bis(trichloromethyl)-s-triazine, 2-phenylvinyl-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(p-methoxyphenyl)vinyl]-4 , 6-bis(trichloromethyl)-s-triazine, 2-[2-(o-methoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(p-butoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4-dimethoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4,5-trimethoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-(1-naphthyl)-4,6-bis(trichloromethyl)-s-triazine , 2-(4-biphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N,N-bis(2-hydroxyethyl)amino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N-hydroxyethyl-N-ethylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N-hydroxyethyl-N-methylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N,N-diallylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine. Among them, 2,4,6-tris(trichloromethyl)-s-triazine is preferred.
[0049] As the iodonium salt compound, any known compound can be used. As a specific example, the structural formula of the iodonium salt compound can be represented by the following formula (1).
[0050] [(R1)2I] + [A] - Formula (1)
[0051] ([(R1)2I] +is the cationic part, [A] - is an anion part, R1 shown in formula (1) represents an organic group bonded to I, and R1 is the same or different. For example, R1 represents an aryl group having 6 to 30 carbon atoms, a heterocyclic group having 4 to 30 carbon atoms, an alkyl group having 1 to 30 carbon atoms, an alkenyl group having 2 to 30 carbon atoms, or an alkynyl group having 2 to 30 carbon atoms, and these groups may be substituted by at least one selected from the group consisting of alkyl, hydroxy, alkoxy, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, arylthiocarbonyl, acyloxy, arylthio, alkylthio, aryl, heterocyclic, aryloxy, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, alkyleneoxy, amino, cyano, nitro, etc., and halogen.)
[0052] Examples of the aryl group having 6 to 30 carbon atoms include monocyclic aryl groups such as phenyl and condensed polycyclic aryl groups such as naphthyl, anthracenyl, phenanthrenyl, pyrenyl, chrysenyl, naphthacenyl, benzanthryl, anthraquinolyl, fluorenyl, naphthoquinone and anthraquinone.
[0053] Examples of the heterocyclic group having 4 to 30 carbon atoms include cyclic substances containing 1 to 3 heteroatoms such as oxygen, nitrogen, and sulfur, and these heteroatoms may be the same or different. Specific examples include monocyclic heterocyclic groups such as thienyl, furanyl, pyranyl, pyrrolyl, oxazolyl, thiazolyl, pyridyl, pyrimidinyl, and pyrazinyl, and indolyl, benzofuranyl, isobenzofuranyl, benzothienyl, isobenzothienyl, quinolyl, isoquinolyl, quinoxalinyl, and quinazoline. Condensed polycyclic heterocyclic groups include benzophenone, carbazolyl, acridinyl, phenothiazinyl, phenazinyl, xanthenyl, thianthrenyl, phenoxazinyl, phenoxathiol, chromanyl, isochromanyl, dibenzothiophenyl, xanthonyl, thioxanthonyl, and dibenzofuranyl.
[0054] Specific examples of the alkyl group having 1 to 30 carbon atoms include straight-chain alkyl groups such as methyl, ethyl, propyl, butyl, hexadecyl and octadecyl; branched-chain alkyl groups such as isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl, tert-pentyl and isohexyl; and cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
[0055] Specific examples of the alkenyl group having 2 to 30 carbon atoms include straight-chain or branched alkenyl groups such as vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl and 1-methyl-1-propenyl.
[0056] Specific examples of the alkynyl group having 2 to 30 carbon atoms include linear or branched alkynyl groups such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-1-propynyl and 1-methyl-2-propynyl.
[0057] The above-mentioned aryl group having 6 to 30 carbon atoms, heterocyclic group having 4 to 30 carbon atoms, alkyl group having 1 to 30 carbon atoms, alkenyl group having 2 to 30 carbon atoms or alkynyl group having 2 to 30 carbon atoms may or may not have at least one substituent. Specific examples of the substituent include straight-chain alkyl groups having 1 to 18 carbon atoms, such as methyl, ethyl, propyl, butyl and octadecyl groups; branched-chain alkyl groups having 1 to 18 carbon atoms, such as isopropyl, isobutyl, sec-butyl and tert-butyl groups; cycloalkyl groups having 3 to 18 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl groups; hydroxyl groups; straight-chain or branched alkyl groups having 1 to 18 carbon atoms, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy and dodecyloxy groups; branched alkoxy; straight-chain or branched alkylcarbonyl having 2 to 18 carbon atoms, such as acetyl, propionyl, butyryl, 2-methylpropionyl, heptanoyl, 2-methylbutyryl, 3-methylbutyryl, octanoyl; arylcarbonyl having 7 to 11 carbon atoms, such as benzoyl and naphthoyl; straight-chain or branched alkoxycarbonyl having 2 to 19 carbon atoms, such as methoxycarbonyl, ethoxycarbonyl, propyloxycarbonyl, isopropyloxycarbonyl, butoxycarbonyl, isobutyloxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl; aryloxycarbonyl having 7 to 11 carbon atoms, such as phenoxycarbonyl and naphthoxycarbonyl; arylthiocarbonyl having 7 to 11 carbon atoms, such as phenylthiocarbonyl and naphthoxythiocarbonyl; acetoxy, ethylcarbonyloxy, propylcarbonyloxy, isobutylcarbonyloxy, sec-butylcarbonyloxy, tert-butyl a phenylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group a linear or branched alkylthio group having 1 to 18 carbon atoms, such as neopentylthio and dodecylthio; an aryl group having 6 to 10 carbon atoms, such as phenyl, tolyl, xylyl and naphthyl; a heterocyclic group having 4 to 20 carbon atoms, such as thienyl, furanyl, pyranyl, xanthyl, chromanyl, isochromanyl, xanthone, thioxanthone and dibenzofuranyl; an aryloxy group having 6 to 10 carbon atoms, such as phenoxy and naphthoxy; a linear or branched alkylsulfinyl group having 1 to 18 carbon atoms, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, tert-amylsulfinyl and octylsulfinyl; an arylsulfinyl group having 6 to 10 carbon atoms, such as phenylsulfinyl, tolylsulfinyl and naphthylsulfinyl;Straight-chain or branched alkylsulfonyl groups having 1 to 18 carbon atoms, such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, and octylsulfonyl; arylsulfonyl groups having 6 to 10 carbon atoms, such as phenylsulfonyl, tolylsulfonyl (toluenesulfonyl), and naphthylsulfonyl; alkyleneoxy groups; cyano groups; nitro groups; halogens such as fluorine, chlorine, bromine, and iodine;
[0058] Among iodonium salt compounds, aryl iodonium salts are preferred due to their high stability. In addition, in order to improve fat solubility, it is preferred that the aryl group has a substituent. Specifically, a linear alkyl group such as methyl, propyl, octyl, decyl, undecyl, dodecyl, tridecyl, or a branched alkyl group such as isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl, tert-pentyl, isohexyl, or a functional group in which one or more H in these groups is replaced by F, or a perfluoroalkyl group, a halogen, or the like is preferably used as a substituent.
[0059] There is no particular limitation on the structure of the anion part of the iodonium salt-based compound. For example, structures with atoms such as halogen, P, S, B, Al, and Ga can be cited. From the viewpoint of safety, anions with As or Sb can be used, but are not preferred in dental applications. In addition, the anion preferably has organic groups such as alkyl and / or alkoxy and / or aryl, and most preferably has organic groups such as alkyl and / or alkoxy and / or aryl substituted with at least one H by F. Since the iodonium salt-based compound with such an anion has high solubility in the photocurable composition, it is expected to prevent precipitation during low temperature storage or long-term storage, and to shorten the manufacturing time by dissolving in the composition in a short time. In addition, the iodonium salt-based compound composed of anions of organic groups such as alkyl and / or alkoxy and / or aryl substituted with one or more H by F can expect higher solubility. In the case of precipitation of the photoacid generator, it is not preferred because there is a reduction in light color stability or a reduction in bending strength. For such anions having organic groups such as alkyl and / or alkoxy and / or aryl groups in which at least one H may be substituted with F, anions having any atoms can be used, but from the viewpoint of versatility and safety, substances having P, S, B, Al, and Ga are preferred.
[0060] Examples of anions not having an alkyl group and / or an alkoxy group and / or an aryl group include halogens such as chlorides and bromides, perhalogen acids such as perchloric acid, aromatic sulfonic acids such as p-toluenesulfonate, camphorsulfonic acid, nitrates, acetates, chloroacetates, carboxylates, phenolates, tetrafluoroborate, hexafluorophosphate, hexafluoroantimonate, hexafluoroarsenate, etc. Among them, p-toluenesulfonate, camphorsulfonic acid, and carboxylates are preferably used.
[0061] Since the iodonium salt compound of formula (1) [A] -The anion part improves the solubility in the photopolymerizable composition, and therefore preferably has an organic group such as an alkyl group and / or an alkoxy group and / or an aryl group in which at least one H is replaced by F. Specifically, the iodonium salt compound of formula (1) [A] - The preferred carbon number of the alkyl group in the anion part is 1 to 8, preferably 1 to 4. Specific examples include straight-chain alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, and octyl; branched-chain alkyl groups such as isopropyl, isobutyl, sec-butyl, and tert-butyl; cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The ratio of the number of hydrogen atoms to fluorine atoms (F / H) in the alkyl group is 4 or more, and the ratio of the number of hydrogen atoms to fluorine atoms (F / H) in the alkyl group is preferably 9 or more. It is further preferred that all hydrogen atoms of the hydrocarbon are substituted by fluorine. Ionium salts composed of anions of alkyl groups having different ratios of hydrogen atoms to fluorine atoms can also be incorporated into the photocurable composition.
[0062] In addition, specific examples of the alkyl group include linear or branched perfluoroalkyl groups such as CF3, CF3CF2, (CF3)2CF, CF3CF2CF2, CF3CF2CF2CF2, (CF3)2CFCF2, CF3CF2(CF3)CF, and (CF3)3C.
[0063] [A] of the iodonium salt compound of formula (1) - The preferred carbon number of the alkoxy group in the anion part is 1 to 8, preferably 1 to 4. As specific examples, straight-chain alkoxy groups such as methoxy, ethoxy, propoxy, butoxy, pentyloxy, octyloxy, or branched alkoxy groups such as isopropoxy, isobutoxy, sec-butoxy, tert-butoxy can be cited. The ratio of the number of hydrogen atoms to fluorine atoms in the alkyl group (F / H) is 4 or more, and the ratio of the number of hydrogen atoms to fluorine atoms in the alkyl group (F / H) is preferably 9 or more. It is further preferred that all hydrogen atoms of the hydrocarbon are substituted by fluorine. Ionium salts composed of anions having alkoxy groups with different ratios of hydrogen atoms to fluorine atoms can also be incorporated into the photocurable composition.
[0064] In addition, specific examples of alkoxy groups include linear or branched perfluoroalkoxy groups such as CF3O, CF3CF2O, CF3CF2CF2O, (CF3)2CFO, CF3CF2CF2CF2O, (CF3)2CFCF2O, CF3CF2(CF3)CFO, CF3CF2CF2CF2CF2O, CF3CF2CF2CF2CF2CF2O, and CF3CF2CF2CF2CF2CF2CF2CF2CF2O.
[0065] In the iodonium salt compound of formula (1), [A] -The phenyl group of the anion part has at least one hydrogen atom substituted by a fluorine atom and / or an alkyl group and / or an alkoxy group substituted by a fluorine atom. The alkyl group and / or the alkoxy group substituted by a fluorine atom are preferably the above-mentioned groups. As a specific example of a particularly preferred phenyl group, pentafluorophenyl (C6F5), trifluorophenyl (C6H2F3), tetrafluorophenyl (C6HF4), trifluoromethylphenyl (CF3C6H4), bis (trifluoromethyl)phenyl ((CF3)2C6H3), pentafluoroethylphenyl (CF3CF2C6H4), bis (pentafluoroethyl)phenyl ((CF3CF2)2C6H3), trifluoromethylfluorophenyl (CF3C6H3F), bis trifluoromethylfluorophenyl ((CF3)2C6H2F), pentafluoroethylfluorophenyl (CF3CF2C6H3F), bis pentafluoroethylfluorophenyl ((CF3CF2)2C6H2F) and other perfluorophenyl groups can be cited. The photocurable composition may further contain an iodonium salt composed of an anion having a phenyl group having a different ratio of hydrogen atoms to fluorine atoms.
[0066] [A] as the iodonium salt compound of formula (1) - Specific examples of anions having P include [(CF3CF2)3PF3] - 、[(CF3CF2CF2)3PF3] - 、[((CF3)2CF)2PF4] - 、[((CF3)2CF)3PF3] - 、[((CF3)2CF)4PF2] - 、[((CF3)2CFCF2)2PF4] - 、[((CF3)2CFCF2)3PF3] - etc. Anions containing S include [(CF3SO2)3C] - 、[(CF3CF2SO2)3C] - 、[(CF3CF2CF2SO2)3C] - 、[(CF3CF2CF2CF2SO2)3C] - , [CF3CF2CF2CF2SO3] - , [CF3CF2CF2SO3] - 、[(CF3CF2SO2)3C] - 、[(SO2CF3)3N] - 、[(SO2CF2CF3)2N] - 、[((CF3)C6H4)SO3] - 、[SO3((CF2CF2CF2CF2)SO3] 2-As anion having B, [B(C6F5)4] - 、[(C6H5)B(C6F5)3] - 、[(C6H5)B((CF3)2C6H3))3] - As anions containing Ga, [((CF3)4Ga) - 、[Ga(C6F5)4] - As anions containing Al, [((CF3)3CO)4Al] - 、[((CF3CF2)3CO)4Al] - wait.
[0067] In the dental photocurable composition of the present invention, the photoacid generator (C) contains an iodonium salt compound (C-1) formed with an anion having a logS of -4 or less.
[0068] LogS is an index of the solubility of a compound in water, and is used to predict the water solubility of a compound. In the present invention, chemical drawing professional software (ChemDraw Professional ver18.1) is used for calculation. The larger the logS value, the higher the water solubility, and the smaller the logS value, the lower the water solubility. As an index showing characteristics according to the structure of this compound, it is known that there are distribution coefficients, HSP (Hansen solubility parameters), tPSA (topological geometry polar surface area) etc. of LogP, CLogP, AlogP, LogD, etc. These indexes are compared with the experimental results, and the results confirm the correlation between the above-mentioned indexes related to solubility and the experimental results, wherein, based on logS, a study was conducted, and it was found that by using iodonium salt-based compounds, the storage stability of dental photocurable compositions during low temperature storage is improved. It is believed that by coordinating a photoacid generator with high solubility in a dental photocurable composition, it will not precipitate even when stored at low temperature, and sufficient physical properties are also shown when it is restored to room temperature. In addition, it is also confirmed that the storage stability during storage under high temperature conditions is also excellent. Such iodonium salts have a high correlation with ClogP in the above-mentioned indexes, and generally, there is a tendency that the greater the value of logS, the lower the ClogP. When ClogP is used as an index, iodonium salts formed with anions showing more than one ClogP are preferred. In the present invention, since it can be judged that it is applicable to a large number of compounds when logS is used as an index, the development of the present invention is completed by conducting research using logS.
[0069] Examples of anions with a logS value of -4 or less include [(CF3CF2)3PF3] - 、[(CF3CF2CF2)3PF3] -、[((CF3)2CF)2PF4] - 、[((CF3)2CF)3PF3] - 、[((CF3)2CF)4PF2] - 、[((CF3)2CFCF2)2PF4] - 、[((CF3)2CFCF2)3PF3] - 、[(CF3CF2SO2)3C] - 、[(CF3CF2CF2SO2)3C] - 、[(CF3CF2CF2CF2SO2)3C] - 、[B(C6F5)4] - 、[(C6H5)B(C6F5)3] - 、[(C6H5)B((CF3)2C6H3))3] - 、[((CF3)4Ga] - 、[Ga(C6F5)4] - 、[((CF3)3CO)4Al] - 、[((CF3CF2)3CO)4Al] - wait.
[0070] On the other hand, if we take anions with logS greater than -4, i.e., anions with low fat solubility, we can cite chloride, bromide, nitrate, perchlorate, tetrafluoroborate, hexafluoroantimonate, hexafluorophosphate, p-toluenesulfonate, trifluoromethanesulfonate, etc. Such anions have high water solubility due to their high logS values, but low fat solubility due to their low ClogP values. For example, the ClogP of the anions shown above is 1 or less.
[0071] The logS of the anion in the iodonium salt-based compound (C-1) is -4 or less, preferably -5 or less. If 0.5 parts by mass or more of an iodonium salt formed with an anion having a logS greater than -4 is added to the dental photocurable composition relative to 100 parts by mass of the total amount of the polymerizable monomer (A), it is possible that the iodonium salt will precipitate when stored under low temperature conditions. In particular, anions with low solubility may not be uniformly dissolved in the dental photocurable composition. In the case where the photoacid generator cannot be uniformly dissolved in the dental photocurable composition or the photoacid generator precipitates, sufficient mechanical properties may not be exhibited, the light color stability may be reduced, and the precipitated photoacid generator may be observed as black spots, thereby affecting the aesthetics.
[0072] Relative to the total amount of 100 parts by mass of (A) polymerizable monomers, it is preferred that the iodonium salt compound formed by (C-1) and anions having a logS of -4 or less contain 0.5 parts by mass or more, and it is further preferred that it contain 1.0 parts by mass or more. When it is less than 0.5 parts by mass, the bending strength is sometimes insufficient, and when it is 0.5 to less than 1.0 parts by mass, there is a tendency that the bending strength is lower than the case containing 1.0 parts by mass or more. On the other hand, relative to the total amount of 100 parts by mass of (A) polymerizable monomers, the iodonium salt compound formed by (C-1) and anions having a logS of -4 or less is preferably 10 parts by mass or less, and it is further preferred that it is 5 parts by mass or less. When it contains more than 10 parts by mass, it may sometimes cause a decrease in ambient light stability, a decrease in light color stability, etc. In addition, since it is not expected that the bending strength can be significantly improved by increasing the amount of the iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less when between 5 and 10 parts by mass, the amount is most preferably 1.0 to 5.0 parts by mass relative to 100 parts by mass of the total amount of the polymerizable monomer (A). The iodonium salt compound (C-1) can be used alone or in combination of two or more.
[0073] In addition, (C) photoacid generator is not limited to the iodonium salt compound of (C-1), and (C) photoacid generators other than the iodonium salt compound of (C-1) can be used in combination. In this case, for the dental photocurable composition of the present invention, the amount of the (C) photoacid generator containing the iodonium salt compound of (C-1) is preferably 0.5 to 10.0 parts by mass relative to 100 parts by mass of the total amount of the polymerizable monomer (A). More preferably, it is 1.0 to 5.0 parts by mass. When the amount is less than 0.5 parts by mass, the polymerization promoting ability may be lacking and the curing may be insufficient. When the amount is greater than 10 parts by mass, although it has sufficient curability, the ambient light stability may be shortened and the discoloration of the cured body such as browning may increase.
[0074] The dental photocurable composition of the present invention may contain only the iodonium salt compound (C-1) as the (C) photoacid generator. The dental photocurable composition of the present invention may contain only the salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation, i.e., an aryl iodonium salt. The dental photocurable composition of the present invention may contain only the salt of an anion having an organic group in which at least one H is substituted with F and one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation as the (C) photoacid generator.
[0075] [(D) Photopolymerization accelerator]
[0076] The (D) photopolymerization accelerator used in the dental photocurable composition of the present invention is not particularly limited as long as it has the ability to promote polymerization, and any known photopolymerization accelerator commonly used in the dental field can be used without any restriction. As the photopolymerization accelerator, primary to tertiary amine compounds such as aromatic amine compounds and aliphatic amine compounds, organic metal compounds, phosphine compounds, etc. can be used. Among them, aliphatic tertiary amine compounds and organic metal compounds are preferred because of their excellent light color stability.
[0077] An aromatic amine compound refers to a compound in which one or more H of ammonia (NH3) is substituted with an aromatic ring. A compound in which one H of NH3 is substituted with an aromatic ring can be classified as an aromatic primary amine compound, a compound in which one H of NH3 is substituted with an aromatic ring and one different H is substituted with an aromatic ring or an alkyl group can be classified as an aromatic secondary amine compound, and a compound in which one H of NH3 is substituted with an aromatic ring and two different Hs are substituted with aromatic rings or an alkyl group can be classified as an aromatic tertiary amine compound.
[0078] Specific examples of the aromatic primary amine compound include aniline, etc. Specific examples of the aromatic secondary amine compound include N-phenylbenzylamine, N-benzyl-p-anisidine, N-benzyl-o-aminophenylethyl ether, N-phenylglycine ethyl ester, N-phenylglycine such as N-protected amino acids (esters), etc. Specific examples of the aromatic tertiary amine compound include N,N-dimethylaniline, N,N-diethylaniline, N,N-di-n-butylaniline, N,N-dimethyl-p-toluidine, N,N-dimethyl-m-toluidine, N,N-diethyl-p-toluidine, p-bromo-N,N-dimethylaniline, m-chloro-N,N-dimethylaniline. , p-dimethylaminobenzaldehyde, p-dimethylaminoacetophenone, p-dimethylaminobenzoic acid, ethyl p-dimethylaminobenzoate, isopentyl p-dimethylaminobenzoate, 2-butoxyethyl p-dimethylaminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, amino p-dimethylaminobenzoate, methyl N,N-dimethyl anthranilate, N,N-dihydroxyethylaniline, N,N-dihydroxyethyl p-toluidine, p-dimethylaminophenyl alcohol, p-dimethylaminostyrene, N,N-dimethyl-3,5-dimethylaniline, 4-dimethylaminopyridine, N,N-dimethyl-α-naphthylamine, N,N-dimethyl-β-naphthylamine, etc.
[0079] Specific examples of the above-mentioned organic metal compounds include organic metal compounds containing scandium (Sc), titanium (Ti), vanadium (V), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), tin (Sn), zinc (Zn), and zirconium (Zr), preferably organic metal compounds containing tin (Sn), vanadium (V), and copper (Cu). Specific examples of the organometallic compound containing tin (Sn) include dibutyltin diacetate, dibutyltin dimaleate, dioctyltin dimaleate, dioctyltin dilaurate, dibutyltin dilaurate, dioctyltin ditert-carbonate, S,S'-dioctyltin diisooctylthioacetate, tetramethyl-1,3-diacetoxydistannoxane, etc. Specific examples of the organometallic compound containing vanadium (V) include vanadium acetylacetonate, vanadium tetroxide, vanadium acetylacetonate, vanadium oxide stearate, vanadium oxalate, vanadium sulfate, di(1-phenyl-1,3-butanedione)oxyvanadium, bis(maltol)oxyvanadium, vanadium pentoxide, sodium metavanadate, etc. Specific examples of the organometallic compound containing copper (Cu) include copper acetylacetonate, copper naphthenate, copper octoate, copper stearate, and copper acetate.
[0080] The phosphine compound refers to a compound in which an organic group is trisubstituted on the P atom, and the aromatic phosphine compound refers to a compound in which a phenyl group is substituted and which may or may not have one or more substituents on the P atom. Specific examples of the phosphine compound include trimethylphosphine, tributylphosphine, trihexylphosphine, tri-n-octylphosphine, tricyclohexylphosphine, tri(2-thienyl)phosphine, diphenylpropylphosphine, di-tert-butyl(3-methyl-2-butenyl)phosphine, methyldiphenylphosphine, triphenylphosphine, 2-(diphenylphosphino)styrene, 3-(diphenylphosphino)styrene, 4-(diphenylphosphino)styrene, allyldiphenylphosphine, 2-(diphenylphosphino)benzaldehyde, 3-(diphenylphosphino)benzaldehyde, 4-(diphenylphosphino)benzaldehyde, 2-(phenylphosphino)benzoic acid ... 1-(phenylphosphino)benzoic acid, 4-(phenylphosphino)benzoic acid, tri(2-methoxyphenyl)phosphine, tri(3-methoxyphenyl)phosphine, tri(4-methoxyphenyl)phosphine, 2-(diphenylphosphino)biphenyl, tri(4-fluorophenyl)phosphine, tri(o-tolyl)phosphine, tri(m-tolyl)phosphine, tri(p-tolyl)phosphine, 2-(dimethylamino)phenyldiphenylphosphine, 3-(dimethylamino)phenyldiphenylphosphine, 4-(dimethylamino)phenyldiphenylphosphine, 2,2'-bis(diphenylphosphino)biphenyl, bis[2-(diphenylphosphino)phenyl]ether, etc. Among them, triphenylphosphine, 4-(phenylphosphino)benzoic acid, tri(o-tolyl)phosphine, tri(m-tolyl)phosphine, and tri(p-tolyl)phosphine are preferred.
[0081] Aliphatic amine compounds refer to compounds in which one or more H of ammonia (NH3) is replaced by an alkyl group. For alkyl groups, CH3- or -CH2- is classified as a primary alkyl group, an alkyl group in which one H of -CH2- is substituted is classified as a secondary alkyl group, and an alkyl group in which two H of -CH2- are substituted is classified as a tertiary alkyl group. For aliphatic amines, an aliphatic amine in which one H of NH3 is substituted by an alkyl group is classified as an aliphatic primary amine compound, an aliphatic amine in which two H of NH3 are substituted by an alkyl group is classified as an aliphatic secondary amine compound, and an aliphatic amine in which three H of NH3 are substituted by an alkyl group is classified as an aliphatic tertiary amine compound.
[0082] Specific examples of aliphatic primary amine compounds include diphenylmethylamine, triphenylmethylamine, amino acids or amino acid esters such as glycine, and the like. Specific examples of aliphatic secondary amine compounds include dibenzylamine, N-benzyl-1-phenylethylamine, bis(1-phenylethyl)amine, bis(4-cyanobenzyl)amine, N-benzyl protected amino acids or N-benzyl protected amino acid esters, and specific examples of aliphatic tertiary amine compounds include tributylamine, tripropylamine, triethylamine, N,N-dimethylhexylamine, N,N-dimethyldodecylamine, N,N-dimethylstearylamine, N-[ 3-(dimethylamino)propyl] acrylamide, N,N-dimethylformamide dimethyl acetal, N,N-dimethylacetamide dimethyl acetal, N,N-dimethylformamide diethyl acetal, N,N-dimethylformamide dipropyl acetal, N,N-dimethylformamide di-tert-butyl acetal, 1-(2-hydroxyethyl)ethyleneimine, N,N-dimethylethanolamine, N,N-dimethylisopropanolamine, N,N-diisopropylethanolamine, N-methyldiethanolamine, N-ethyldiethanolamine, N-ethyldiethanolamine, N-butyldiethanolamine, N-lauryldiethanolamine Ethanolamine, N-stearyl diethanolamine, triethanolamine, tribenzylamine, dibenzylglycine ethyl ester, N'-(2-hydroxyethyl)-N,N,N'-trimethylethylenediamine, 2-(dimethylamino)-2-methyl-1-propanol, N,N-dimethyl-2,3-dihydroxypropylamine, N,N-diethylethanolamine, 1-methyl-3-pyrrolidinol, 1-(2-hydroxyethyl)pyrrolidine, 1-isopropyl-3-pyrrolidinol, 1-piperidinol, 2-[2-(dimethylamino)ethoxy]ethanol, N,N-dimethylglycine, N,N-dimethyl N,N-diethylglycine methyl ester, N,N-dimethylglycine ethyl ester, N,N-diethylglycine sodium, 2-(dimethylamino)ethyl acetate, N-methyliminodiacetic acid, N,N-dimethylaminoethyl acrylate, N,N-diethylaminoethyl methacrylate, N,N-dibutylaminoethyl methacrylate, N,N-dibenzylaminoethyl methacrylate, 3-dimethylaminopropionitrile, tris(2-cyanoethyl)amine, N,N-dimethylallylamine, N,N-diethylallylamine, triallylamine, etc.
[0083] (D) It is particularly preferred to use an aliphatic tertiary amine compound as a photopolymerization accelerator. Since the light color stability of aromatic amine compounds is poor, if used for prosthetic devices, restorative materials, and adhesives in parts that are easily irradiated by light such as front teeth, the color tone sometimes changes over time, and is therefore not preferred. In addition, by using a UV absorber in combination, it is possible to expect to suppress the discoloration caused by light over time. However, the UV absorber is used as a common additive, so it is not possible to expect the improvement of the mechanical and physical properties brought about by the coordination, and there is also a situation in which the yellow tone of the dental photocurable composition before curing is increased, so it is not preferred to coordinate in large quantities. For these reasons, it is preferred to use an aliphatic tertiary amine compound. In addition, depending on the composition of the dental photocurable composition, high storage stability and high mechanical strength can be expected when containing an aliphatic primary amine compound and an aliphatic secondary amine compound, so known substances can be used without any restrictions.
[0084] In addition, among the aliphatic tertiary amine compounds, it is preferred that the amine compound does not have more than two primary hydroxyl groups in the molecule, and it is further preferred that the amine compound does not have a primary hydroxyl group in the molecule. As specific examples of the amine compound having more than two primary hydroxyl groups in the molecule, triethanolamine, methyldiethanolamine, etc. can be cited. When the cured body of the dental photocurable composition is stored for a long time, the amine compound having a primary hydroxyl group sometimes causes discoloration. The more the number of primary hydroxyl groups in the molecule, the more the discoloration tends to increase, which is particularly significant when there are more than two in the molecule. The discoloration during long-term storage of the cured body can be confirmed in a short period of time by storing it under high temperature water conditions. When the discoloration is small under high temperature water conditions, that is, when the thermal color stability is high, the discoloration during long-term use of the cured body of the dental photocurable composition is small.
[0085] The (D) photopolymerization accelerator is preferably 0.01 to 20 parts by mass, and more preferably 0.1 to 10 parts by mass, relative to 100 parts by mass of the total amount of the (A) polymerizable monomer contained in the dental photopolymerizable composition. When it is less than 0.01 parts by mass, the mechanical strength may be insufficient. When it is more than 20 parts by mass, although it has sufficient curability, there are cases where the ambient light stability is shortened or the cured body has increased discoloration such as brown, so it is not preferred.
[0086] As required, there is no problem in performing secondary treatments such as fine grinding, carrier adsorption, and microcapsulation of these (B) photosensitizers, (C) photoacid generators, and (D) photopolymerization accelerators as polymerization initiators. Furthermore, regardless of the polymerization mode or polymerization method, these various photopolymerization initiators can be used alone or in combination of two or more.
[0087] The dental photocurable composition of the present invention may contain only aliphatic tertiary amine compounds as (D) photopolymerization accelerators. The dental photocurable composition of the present invention may contain only (D-1) aliphatic tertiary amine compounds not having two or more primary hydroxyl groups as (D) photopolymerization accelerators. The dental photocurable composition of the present invention may contain only aliphatic tertiary amine compounds not having primary hydroxyl groups in the molecule as (D) photopolymerization accelerators.
[0088] [(E) Filler]
[0089] The dental photopolymerizable composition of the present invention may contain (E) a filler as another component. As the (E) filler used in the present invention, a commonly used known filler may be used without any limitation.
[0090] The type of filler (E) is not limited as long as it is a known filler, and can be mixed with fillers according to its use, preferably with fillers such as inorganic fillers, organic fillers or organic-inorganic composite fillers. These fillers can be used not only alone, but also in combination with multiple types regardless of the type of filler.
[0091] As the above-mentioned inorganic filler, there is no particular limitation on their chemical composition, and specific examples thereof include silica, alumina, silica-titania, silica-titania-barium oxide, silica-zirconium oxide, silica-alumina, lanthanum glass, borosilicate glass, soda glass, barium glass, strontium glass, glass ceramics, aluminosilicate glass, barium boroaluminosilicate glass, strontium boroaluminosilicate glass, aluminum fluorosilicate glass, calcium aluminum fluorosilicate glass, strontium aluminum fluorosilicate glass, barium aluminum fluorosilicate glass, strontium calcium aluminum fluorosilicate glass, etc. In particular, barium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, and fluoroaluminosilicate glass, etc., which are used for dental glass ionomer cement, resin reinforced glass ionomer cement, and resin cement, etc., can also be preferably used. The fluoroaluminosilicate glass described herein has silica and alumina as the basic skeleton and includes an alkali metal for introducing non-crosslinking oxygen. Furthermore, it has alkaline earth metals including strontium as modifying / coordinating ions and fluorine. In addition, in order to further impart X-ray opacity, it is a composition in which a lanthanide element is incorporated into the framework. The lanthanide element is also incorporated into the composition as a modifying / coordinating ion depending on the composition domain.
[0092] Specific examples of the organic filler include polymers such as polymethyl methacrylate, polyethyl methacrylate, methyl methacrylate-ethyl methacrylate copolymer, ethyl methacrylate-butyl methacrylate copolymer, methyl methacrylate-trimethylolpropane methacrylate copolymer, polyvinyl chloride, polystyrene, chlorinated polyethylene, nylon, polysulfone, polyethersulfone, and polycarbonate.
[0093] Examples of organic-inorganic composite fillers include composite fillers obtained by coating the surface of a filler with a polymerizable monomer, composite fillers obtained by mixing a filler and a polymerizable monomer, polymerizing the mixture, and then crushing the mixture into an appropriate particle size, or composite fillers obtained by preliminarily dispersing the filler in a polymerizable monomer and then performing emulsion polymerization or suspension polymerization, but the present invention is not limited to these composite fillers.
[0094] In order to improve the affinity with polymerizable monomers, the dispersibility in polymerizable monomers, the mechanical strength and water resistance of the cured body, the above-mentioned (E) filler can be treated with a surface treatment material represented by a silane coupling agent. This surface treatment material and surface treatment method are not particularly limited, and known methods can be adopted without restriction. As the silane coupling agent for the surface treatment of the filler, preferably methyltrimethoxysilane, methyltriethoxysilane, methyltrichlorosilane, dimethyldichlorosilane, trimethylchlorosilane, vinyltrichlorosilane, vinyltriethoxysilane, vinyltri(2-methoxyethoxy)silane, 3-methacryloxypropyltrimethoxysilane, 3-chloropropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-(methyl)acryloxypropyltrimethoxysilane, 8-(methyl)acryloxyoctyltrimethoxysilane, 11-(methyl)acryloxyundecyltrimethoxysilane or hexamethyldisilazane etc. In addition, the surface treatment of the filler can be carried out by using a titanate coupling agent or an aluminate coupling agent in addition to a silane coupling agent. The treatment amount of the surface treatment material in the filler is preferably 0.01 to 30 parts by mass, more preferably 0.5 to 20 parts by mass, relative to 100 parts by mass of the filler before treatment.
[0095] The shape of the filler is not particularly limited, and fillers of any shape such as amorphous, spherical, needle-shaped, plate-shaped, crushed, flaky, etc. can be used. In addition, the average particle size of the filler is preferably 0.2 μm to 50 μm, more preferably 0.2 μm to 30 μm, further preferably 0.2 μm to 20 μm, and further preferably 0.2 μm to 10 μm.
[0096] When the filler (E) is added to the dental photocurable composition, the amount is preferably 10 to 1000 parts by mass relative to 100 parts by mass of the total amount of the polymerizable monomer (A), and preferably less than 500 parts by mass in consideration of the excipient property, etc. When the amount of the filler is less than 10 parts by mass, there is a lack of mechanical strength when the filler is added, and the effect of expressing the thixotropic property is lacking. When the amount of the filler is greater than 1000 parts by mass, the paste-like state of the composition becomes hard and sometimes difficult to handle. There is also a case where more than 1000 parts by mass are included depending on the type of filler and the surface treatment conditions of the filler. For example, this refers to a case where the filler has a high specific gravity, a case where the amount of the surface treatment agent in the filler is large, or a case where a surface treatment agent with good affinity to the polymerizable monomer is used. Regardless of the amount of the filler, the composition of the present invention exhibits an effect.
[0097] The dental photocurable composition of the present invention may contain a chemical polymerization initiator. Organic peroxides as chemical polymerization initiators include diacyl peroxides, peroxyesters, dialkyl peroxides, peroxyketals, ketone peroxides, peroxydicarbonates, and hydroperoxides. Specific examples of diacyl peroxides include acetyl peroxide, isobutyryl peroxide, benzoyl peroxide, decanoyl peroxide, 3,5,5-trimethylhexanoyl peroxide, 2,4-dichlorobenzoyl peroxide, and lauroyl peroxide. Specific examples of the peroxyesters include α-cumyl peroxyneodecanoate, t-butyl peroxyneodecanoate, t-butyl peroxypivalate, 2,2,4-trimethylpentyl peroxy-2-ethylhexanoate, t-amyl peroxy-2-ethylhexanoate, t-butyl peroxy-2-ethylhexanoate, di-t-butyl peroxyisophthalate, di-t-butyl peroxyhexahydroterephthalate, t-butyl peroxy-3,3,5-trimethylhexanoate, t-butyl peroxyacetate, t-butyl peroxybenzoate, and t-butyl peroxymaleate. Specific examples of dialkyl peroxides include di-tert-butyl peroxide, dicumyl peroxide, tert-butyl cumyl peroxide, 2,5-dimethyl-2,5-di(tert-butylperoxy)hexane, 1,3-bis(tert-butylperoxyisopropyl)benzene, and 2,5-dimethyl-2,5-di(tert-butylperoxy)-3-hexyne. Specific examples of peroxyketals include 1,1-di(tert-butylperoxy)cyclohexane, 2,2-di(tert-butylperoxy)butane, n-butyl 4,4-(tert-butylperoxy)valerate, and 1,1-di(tert-amylperoxy)cyclohexane. Specific examples of ketone peroxides include methyl ethyl ketone peroxide, methyl isobutyl ketone peroxide, methylcyclohexanone peroxide, and cyclohexanone peroxide. Specific examples of peroxydicarbonates include di-3-methoxy peroxydicarbonate, di-2-ethylhexyl peroxydicarbonate, bis(4-tert-butylcyclohexyl) peroxydicarbonate, diisopropyl peroxydicarbonate, di-n-propyl peroxydicarbonate, di-2-ethoxyethyl peroxydicarbonate, and diallyl peroxydicarbonate. Specific examples of hydroperoxides include 2,5-dimethylhexane-2,5-dihydroperoxide, diisopropylbenzene hydroperoxide, cumene hydroperoxide, tert-butyl hydroperoxide, and 1,1,3,3-tetramethylbutyl hydroperoxide.
[0098] For organic peroxide, the above-mentioned organic peroxide can be used alone or two or more organic peroxides can be used in combination. Among these organic peroxides, from the viewpoint of curability, preferably benzoyl peroxide and cumene hydroperoxide. From the viewpoint of improving curability, relative to the total amount 100 mass parts of (A) polymerizable monomers, the organic peroxide as a chemical polymerization initiator is preferably set to 0.1~5 mass parts, and further preferably set to 0.3~3 mass parts. In addition, if the amount of organic peroxide is more than 5 mass parts, it is sometimes difficult to fully ensure the operating time. On the other hand, if the amount of organic peroxide is less than 0.1 mass part, the mechanical strength is sometimes insufficient.
[0099] In order to improve the curability, a chemical polymerization accelerator may be added to the dental photocurable composition of the present invention. Examples of the chemical polymerization accelerator include transition metal compounds of the fourth period, thiourea derivatives, aliphatic amines, aromatic amines, sulfinic acid and its salts, borate compounds, sulfur-containing reducing inorganic compounds, nitrogen-containing reducing inorganic compounds, barbituric acid derivatives, triazine compounds, halogen compounds, etc. The amount of the chemical polymerization accelerator is preferably 0.01 to 5 parts by mass, more preferably 0.1 to 3 parts by mass, relative to 100 parts by mass of the total amount of the polymerizable monomers.
[0100] The transition metal compound of the 4th period as a chemical polymerization accelerator refers to a metal compound of Groups 3 to 12 of the 4th period of the periodic table. Specifically, as long as it is a metal compound of scandium (Sc), titanium (Ti), vanadium (V), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), and zinc (Zn), it can be used without limitation. In addition, each of the above-mentioned transition metal elements can take multiple valences, but as long as it is a valence that can exist stably, it can be added to the dental photocurable composition of the present invention. For example, Sc (3 valence), Ti (4 valence), V (3, 4 or 5 valence), Cr (2, 3 or 6 valence), Mn (2 to 7 valence), Fe (2 or 3 valence), Co (2 or 3 valence), Ni (2 valence), Cu (1 or 2 valence), Zn (2 valence). Specific examples of transition metal compounds include scandium iodide (trivalent) and the like as scandium compounds, titanium chloride (quadrivalent) and tetraisopropoxytitanium (quadrivalent) and the like as titanium compounds, and vanadium acetylacetonate (trivalent), vanadium tetroxide (quadrivalent), vanadium acetylacetonate (quadrivalent), vanadium oxide stearate (quadrivalent), vanadium oxalate (quadrivalent), vanadium sulfate (quadrivalent), di(1-phenyl-1,3-butanedione)oxyvanadium (quadrivalent), bis(maltol)oxyvanadium (quadrivalent), vanadium pentoxide (quinavalent), sodium metavanadate (quinavalent) and the like as vanadium compounds. Examples of manganese compounds include manganese acetate (divalent), manganese naphthenate (divalent), etc. Examples of iron compounds include iron acetate (divalent), iron chloride (divalent), iron acetate (trivalent), iron chloride (trivalent), etc. Examples of cobalt compounds include cobalt acetate (divalent), cobalt naphthenate (divalent), etc. Examples of nickel compounds include nickel chloride (divalent), etc. Examples of copper compounds include copper chloride (monovalent), copper bromide (monovalent), copper chloride (divalent), copper acetate (divalent), etc. Examples of zinc compounds include zinc chloride (divalent), zinc acetate (divalent), etc.
[0101] Among them, trivalent or tetravalent vanadium compounds and divalent copper compounds are preferred, wherein trivalent or tetravalent vanadium compounds with higher polymerization promoting ability are more preferred, and tetravalent vanadium compounds are most preferred. These transition metal compounds of the 4th period can be used in combination as needed. Relative to 100 parts by mass of the total amount of (A) polymerizable monomers, the amount of the transition metal compound is preferably 0.0001 to 1 part by mass, and when it is less than 0.0001 parts by mass, the polymerization promoting effect is sometimes insufficient, and when it is greater than 1 part by mass, discoloration or gelation of the dental photocurable composition is caused, and storage stability is sometimes reduced.
[0102] As the thiourea derivative of chemical polymerization accelerator, as long as it is a known thiourea derivative, it can be used without restriction. As a specific example, dimethylthiourea, diethylthiourea, tetramethylthiourea, (2-pyridyl) thiourea, N-methylthiourea, ethylenethiourea, N-allylthiourea, N-allyl-N'-(2-hydroxyethyl) thiourea, N-benzylthiourea, 1,3-dicyclohexylthiourea, N,N'-diphenylthiourea, 1,3-di(p-tolyl)thiourea, 1-methyl-3-phenylthiourea, N-acetylthiourea, N-benzoylthiourea, diphenylthiourea, dicyclohexylthiourea. Among them, preferably (2-pyridyl) thiourea, N-acetylthiourea, N-benzoylthiourea. These thiourea derivatives can be used in combination as needed. The amount of the thiourea derivative is preferably 0.1 to 5 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A). When it is less than 0.1 parts by mass, the polymerization promoting ability may be insufficient, and when it is more than 5 parts by mass, the storage stability may be reduced.
[0103] Examples of the sulfinic acid and its salt include p-toluenesulfinic acid, sodium p-toluenesulfinic acid, potassium p-toluenesulfinic acid, lithium p-toluenesulfinic acid, calcium p-toluenesulfinic acid, benzenesulfinic acid, sodium benzenesulfinic acid, potassium benzenesulfinic acid, lithium benzenesulfinic acid, calcium benzenesulfinic acid, 2,4,6-trimethylbenzenesulfinic acid, sodium 2,4,6-trimethylbenzenesulfinic acid, potassium 2,4,6-trimethylbenzenesulfinic acid, lithium 2,4,6-trimethylbenzenesulfinic acid, calcium 2,4,6-trimethylbenzenesulfinic acid, 2,4,6-triethylbenzenesulfinic acid, 2,4 , 6-triethylbenzenesulfinate sodium, 2,4,6-triethylbenzenesulfinate potassium, 2,4,6-triethylbenzenesulfinate lithium, 2,4,6-triethylbenzenesulfinate calcium, 2,4,6-triisopropylbenzenesulfinic acid, 2,4,6-triisopropylbenzenesulfinate sodium, 2,4,6-triisopropylbenzenesulfinate potassium, 2,4,6-triisopropylbenzenesulfinate lithium, 2,4,6-triisopropylbenzenesulfinate calcium, etc., particularly preferably sodium benzenesulfinate, sodium p-toluenesulfinate, 2,4,6-triisopropylbenzenesulfinate sodium.
[0104] Specific examples of borate compounds having one aromatic group in one molecule include trialkylphenylborane, trialkyl(p-chlorophenyl)borane, trialkyl(p-fluorophenyl)borane, trialkyl(3,5-bistrifluoromethyl)phenylborane, trialkyl[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borane, trialkyl(p-nitrophenyl)borane, trialkyl(m-nitrophenyl)borane, trialkyl(p-butylphenyl)borane, trialkyl(m-butylphenyl)borane, The invention also includes sodium salts, lithium salts, potassium salts, magnesium salts, tetrabutylammonium salts, tetramethylammonium salts, tetraethylammonium salts, methylpyridinium salts, ethylpyridinium salts, butylpyridinium salts, methylquinolinium salts, ethylquinolinium salts, butylquinolinium salts, and the like of trialkyl(p-butoxyphenyl)boron, trialkyl(m-butoxyphenyl)boron, trialkyl(p-octyloxyphenyl)boron and trialkyl(m-octyloxyphenyl)boron (the alkyl group is at least one selected from the group consisting of n-butyl, n-octyl and n-dodecyl, etc.). Specific examples of the borate compound having two aromatic groups in one molecule include dialkyldiphenylborane, dialkyldi(p-chlorophenyl)borane, dialkyldi(p-fluorophenyl)borane, dialkyldi(3,5-bistrifluoromethyl)phenylborane, dialkyldi[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borane, dialkyldi(p-nitrophenyl)borane, dialkyldi(m-nitrophenyl)borane, dialkyldi(p-butylphenyl)borane, dialkyldi(m-butylphenyl)borane, The invention also includes sodium salts, lithium salts, potassium salts, magnesium salts, tetrabutylammonium salts, tetramethylammonium salts, tetraethylammonium salts, methylpyridinium salts, ethylpyridinium salts, butylpyridinium salts, methylquinolinium salts, ethylquinolinium salts and butylquinolinium salts of dialkyldi(p-butoxyphenyl)boron, dialkyldi(m-butoxyphenyl)boron, dialkyldi(p-octyloxyphenyl)boron and dialkyldi(m-octyloxyphenyl)boron (the alkyl group is at least one selected from n-butyl, n-octyl and n-dodecyl groups, etc.). Specific examples of the borate compound having three aromatic groups in one molecule include monoalkyl triphenylborane, monoalkyl tri(p-chlorophenyl)borane, monoalkyl tri(p-fluorophenyl)borane, monoalkyl tri(3,5-bistrifluoromethyl)phenylborane, monoalkyl tri[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borane, monoalkyl tri(p-nitrophenyl)borane, monoalkyl tri(m-nitrophenyl)borane, monoalkyl tri(p-butylphenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl) ...(3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, mono Sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, butylquinolinium salt, etc. of (m-butylphenyl)boron, monoalkyltri(p-butoxyphenyl)boron, monoalkyltri(m-butoxyphenyl)boron, monoalkyltri(p-octyloxyphenyl)boron and monoalkyltri(m-octyloxyphenyl)boron (the alkyl group is one selected from n-butyl, n-octyl or n-dodecyl, etc.).Specific examples include borate compounds having four aromatic groups in one molecule, such as tetraphenylboron, tetrakis(p-chlorophenyl)boron, tetrakis(p-fluorophenyl)boron, tetrakis(3,5-bistrifluoromethyl)phenylboron, tetrakis[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, tetrakis(p-nitrophenyl)boron, tetrakis(m-nitrophenyl)boron, tetrakis(p-butylphenyl)boron, tetrakis(m-butylphenyl)boron, tetrakis(p-butoxyphenyl)boron, tetrakis(m-butoxyphenyl)boron, tetrakis(p-octyloxyphenyl)boron. , sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt and butylquinolinium salt of tetrakis(m-octyloxyphenyl)boron, (p-fluorophenyl)triphenylboron, (3,5-bistrifluoromethyl)phenyltriphenylboron, (p-nitrophenyl)triphenylboron, (m-butoxyphenyl)triphenylboron, (p-butoxyphenyl)triphenylboron, (m-octyloxyphenyl)triphenylboron and (p-octyloxyphenyl)triphenylboron, etc.
[0105] Among these aryl borate compounds, from the viewpoint of storage stability, it is more preferable to use a borate compound having three or four aryl groups in one molecule. In addition, these aryl borate compounds can be used alone or in combination of two or more.
[0106] Examples of the sulfur-containing reducing inorganic compound include sulfites, bisulfites, pyrosulfites, thiosulfates, thionates, dithionites, and the like. Specific examples include sodium sulfite, potassium sulfite, calcium sulfite, ammonium sulfite, sodium bisulfite, potassium bisulfite, 3-mercaptopropyltrimethoxysilane, 2-mercaptobenzoxazole, decanethiol, and thiobenzoic acid.
[0107] Examples of the nitrogen-containing reducing inorganic compound include nitrites, and specific examples thereof include sodium nitrite, potassium nitrite, calcium nitrite, and ammonium nitrite.
[0108] Examples of the barbituric acid derivatives include barbituric acid, 1,3-dimethylbarbituric acid, 1,3-diphenylbarbituric acid, 1,5-dimethylbarbituric acid, 5-butylbarbituric acid, 5-ethylbarbituric acid, 5-isopropylbarbituric acid, 5-cyclohexylbarbituric acid, 1,3,5-trimethylbarbituric acid, 1,3-dimethyl-5-ethylbarbituric acid, 1,3-dimethyl-n-butylbarbituric acid, 1,3-dimethyl-5-isobutylbarbituric acid, 1,3-dimethylbarbituric acid, 1,3-dimethyl-5-cyclopentylbarbituric acid, 1,3-dimethyl-5-cyclohexylbarbituric acid, 1,3-dimethyl-5-phenylbarbituric acid, 1-cyclohexyl-1-ethylbarbituric acid, 1-benzyl-5-phenylbarbituric acid, 5-methylbarbituric acid, 5-propylbarbituric acid, 1,5-diethylbarbituric acid, 1-ethyl-5-methylbarbituric acid, 1-ethyl-5-isobutylbarbituric acid, 1,3-diethyl-5-butylbarbituric acid, 1-cyclohexyl-5-methylbarbituric acid, 1-cyclohexyl-5-ethylbarbituric acid, 1-cyclohexyl-5-octylbarbituric acid, 1-cyclohexyl-5-hexylbarbituric acid, 5-butyl-1-cyclohexylbarbituric acid, 1-benzyl-5-phenylbarbituric acid and salts of thiobarbituric acids (preferably alkali metals or alkaline earth metals). Specific examples of the salts of these barbituric acids include sodium 5-butylbarbiturate, sodium 1,3,5-trimethylbarbiturate and sodium 1-cyclohexyl-5-ethylbarbiturate.
[0109] Specific examples of the halogen compound include dilauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride, benzyltrimethylammonium chloride, tetramethylammonium chloride, benzyldimethylcetylammonium chloride, and dilauryldimethylammonium bromide.
[0110] The dental photocurable composition of the present invention may not contain a chemical polymerization initiator and a chemical polymerization accelerator. The dental photocurable composition of the present invention may not contain a polymerization initiator system of a polymerization system other than a photopolymerization system.
[0111] <Other ingredients>
[0112] In addition, the dental photocurable composition of the present invention may contain components other than the components (A) to (D) as long as the effect of the present invention is not inhibited. For example, benzophenone-based and benzotriazole-based ultraviolet absorbers, hydroquinone, hydroquinone monomethyl ether, 2,5-di-tert-butyl-4-methylphenol and other polymerization inhibitors; α-alkyl styrene compounds, n-butyl mercaptan, n-octyl mercaptan and other thiol compounds; limonene, myrcene, α-terpinene, β-terpinene, γ-terpinene, terpinene, β-pinene, α-pinene and other terpenoid compounds and other chain transfer agents; aminocarboxylic acid chelating agents, phosphonic acid chelating agents and other metal scavenging materials; discoloration inhibitors, antibacterial agents, coloring pigments, water and solvents that can be mixed with water at any ratio, other conventionally known additives and other components can be added as needed.
[0113] There is no particular limitation on the method for preparing the dental photocurable composition of the present invention. As a general method for producing a dental photocurable composition, for example, when the dental photocurable composition contains (E), a method can be cited in which a matrix is prepared by mixing (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator, and then the matrix and the filler (E) are kneaded and bubbles are removed under vacuum to prepare a uniform paste. In the present invention, it is also possible to produce without any problems by the above-mentioned production method.
[0114] The dental photocurable composition of the present invention is used for dental adhesive materials, dental composite resins, dental abutment repair materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing adhesive materials, dental hard resins, dental cutting materials, dental 3D printing materials, etc.
[0115] <One-component dental photocurable composition>
[0116] When the present invention is used in a single-dose dental photocurable composition, it is particularly preferably used as a dental material for dental bonding materials, dental composite resins, dental abutment building materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing bonding materials, dental hard resins, dental cutting materials, and dental 3D printing materials, and is particularly preferably used for dental bonding materials, dental composite resins, dental abutment building materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing bonding materials, and dental hard resins. When it is a single-dose dental photocurable composition, it can be expected that there are few technical errors and a small risk of mixing bubbles.
[0117] <Two-component dental photocurable composition>
[0118] When the present invention is used for a two-component dental photocurable composition, in particular, it is preferably used as a dental material for dental adhesives, dental composite resins, dental abutment construction materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixed adhesives, dental hard resins, dental cutting materials, and dental 3D printing materials, and is particularly preferably used for dental adhesives, dental composite resins, dental abutment construction materials, and dental resin cements. The two-component dental material is used by kneading the two components divided into a first paste and a second paste before use. Kneading is performed with a volume ratio of 0.9 to 1.1:1.0 or a mass ratio of 0.8 to 1.2:1.0 for the first paste and the second paste, preferably an equal volume ratio. The kneading method can be performed by a known method such as manual kneading using a dedicated oscillating device, a scraper, etc., and automatic kneading by a static mixer. Since the components can be divided into two doses, compounds that cannot be formulated in the same paste can be formulated separately, and thus the storage stability is excellent.
[0119] The dental photocurable composition of the present invention comprises (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator, wherein the photoacid generator (C) may comprise only an iodonium salt compound (C-1) formed with an anion having a logS of -4 or less. In addition, as components other than (A) to (D), only one or more of the above components may be included.
[0120] [Example]
[0121] Hereinafter, although the examples of the present invention will be described in detail, the present invention is not limited to these examples.
[0122] The materials and their abbreviations used in Examples and Comparative Examples are as follows.
[0123] [(A) Polymerizable Monomer]
[0124] Bis-GMA: 2,2-bis[4-(3-methacryloyloxy)-2-hydroxypropyloxy)phenyl]propane.
[0125] 2.6E: 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane having an average added ethoxy group mole number of 2.6.
[0126] UDMA: N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)ethanol]methacrylate.
[0127] TEGDMA: triethylene glycol dimethacrylate.
[0128] NPG: neopentyl glycol dimethacrylate.
[0129] HEMA: 2-hydroxyethyl methacrylate.
[0130] MDP: 10-methacryloyloxydecyl dihydrogen phosphate.
[0131] MHPA: 6-methacryloyloxyhexylphosphonoacetate.
[0132] [(B) Photosensitizer]
[0133] CQ: camphorquinone.
[0134] BAPO: phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide.
[0135] [(D) Photopolymerization accelerator]
[0136] <Aliphatic tertiary amine>
[0137] <<Aliphatic tertiary amine compound having no primary hydroxyl group>>
[0138] TBA: tribenzylamine.
[0139] DBGE: N,N-dibenzylglycine ethyl ester.
[0140] DEAEMA: N,N-diethylaminoethyl methacrylate.
[0141] DMAEMA: N,N-dimethylaminoethyl methacrylate.
[0142] <<Aliphatic tertiary amine compound having one primary hydroxyl group>>
[0143] DBAE: N,N-dibenzylaminoethanol.
[0144] <<Aliphatic tertiary amine compound having two primary hydroxyl groups>>
[0145] MDEOA: methyldiethanolamine.
[0146] <<Aliphatic tertiary amine compound having three primary hydroxyl groups>>
[0147] TEA: triethanolamine.
[0148] <Aromatic tertiary amine compounds>
[0149] DMBE: N,N-dimethylaminobenzoic acid ethyl ester.
[0150] <Organometallic compounds>
[0151] DBTL: dibutyltin dilaurate.
[0152] [(E) Filler]
[0153] The production method of each filler used for preparing the photocurable composition is shown below.
[0154] (Padding 1)
[0155] A silane coupling treatment liquid was added to 100.0 g of a zirconium silicate filler (average particle size 1.2 μm: zirconium oxide 90 wt%, silicon dioxide 10 wt%) and stirred for 30 minutes. The silane coupling treatment liquid was obtained by stirring 50.0 g of water, 35.0 g of ethanol, and 7.0 g of 8-methacryloyloxyoctyltrimethoxysilane as a silane coupling agent at room temperature for 2 hours. Then, a heat treatment was performed at 140° C. for 15 hours to obtain a filler 1.
[0156] (Padding 2)
[0157] A silane coupling treatment liquid was added to 100.0 g of zirconium silicate filler (average particle size 0.8 μm, zirconium oxide 85 wt%, silicon dioxide 15 wt%), and stirred for 30 minutes. The silane coupling treatment liquid was obtained by stirring 50.0 g of water, 35.0 g of ethanol, and 7.0 g of 3-methacryloxypropyltrimethoxysilane as a silane coupling agent at room temperature for 2 hours. Then, a heat treatment was performed at 140° C. for 15 hours to obtain filler 2.
[0158] [Chemical polymerization initiator]
[0159] CHP: cumene hydroperoxide.
[0160] BPO: Benzoyl peroxide.
[0161] TPE: 1,1,3,3-tetramethylbutylperoxy-2-ethylhexanoate.
[0162] [Chemical polymerization accelerator]
[0163] PTU: (2-pyridyl)thiourea.
[0164] DEPT: N,N-dihydroxyethyl-p-toluidine.
[0165] DMPT: N,N-dimethyl-p-toluidine.
[0166] COA: Copper acetylacetonate.
[0167] VOA: Vanadyl acetylacetonate.
[0168] [Ultraviolet light absorber]
[0169] BT: 2-(2-hydroxy-5-methylphenyl)benzotriazole.
[0170] [Polymerization inhibitor]
[0171] BHT: 2,6-di-tert-butyl-4-methylphenol.
[0172] ·MeHQ: p-Methoxyphenol.
[0173] [Fluorescent agent]
[0174] FA: diethyl 2,5-dihydroxyterephthalate.
[0175] [(C) Photoacid generator]
[0176] The logS of the hydride of the iodonium salt anion was calculated using ChemDraw Professional ver 18.1.
[0177] <(C-1) Ionium salt compound with an anion having a logS of -4 or less>
[0178] C1: bis[4-(tert-butyl)phenyl]iodonium tetrakis(pentafluorophenyl)gallate (LogS: -15.1).
[0179]
[0180] C2: di-p-tolyliodonium phenyl tris(pentafluorophenyl)borate (LogS: -11.3).
[0181]
[0182] C3: bis(4-tert-butylphenyl)iodonium tetrakis(nonafluoro-tert-butoxy)aluminate (LogS: -14.7).
[0183]
[0184] C4: p-cumyl(p-tolyl)iodonium tris(pentafluoroethanesulfonyl)methide (LogS: -5.3).
[0185]
[0186] C5: diphenyliodonium tris(nonafluorobutanesulfonyl)methide (LogS: -9.4).
[0187]
[0188] C6: bis(4-tert-butylphenyl)iodonium tris(pentafluoropropyl)trifluorophosphate (ClogP: -5.2).
[0189]
[0190] C7: p-cumyl(p-tolyl)iodonium tris(pentafluoroethyl)trifluorophosphate (ClogP: -7.2).
[0191]
[0192] C8: p-cumyl(p-tolyl)iodonium bis(trifluoromethyl)tetrafluorophosphate (ClogP: -4.7).
[0193]
[0194] C9: p-cumyl (p-tolyl) iodonium (trifluoromethyl) pentafluorophosphate (ClogP: -4.1).
[0195]
[0196] <Photoacid generator containing anions having a logS greater than -4>
[0197] C11: bis(4-tert-butylphenyl)iodonium-p-toluenesulfonate (LogS: -2.1).
[0198]
[0199] C12: diphenyliodonium trifluoromethanesulfonate (LogS: -0.7).
[0200]
[0201] C13: diphenyliodonium chloride (LogS: 0.2).
[0202]
[0203] C14: bis(4-tert-butylphenyl)iodonium hexafluorophosphate.
[0204]
[0205] <Method for producing a one-component dental photocurable composition>
[0206] All the components except the filler (E) shown in Table 1 were placed in a wide-mouth plastic container, and mixed for 48 hours using a mixing rotor VMRC-5 at 100 rpm to obtain a matrix. Then, the matrix and the filler (E) were placed in a mixer, uniformly stirred, and then degassed under vacuum to prepare a dental photocurable composition. It should be noted that in Table 1, the mass parts of each component are recorded in brackets after the abbreviation of each component.
[0207] Table 1
[0208]
[0209] <Method for producing two-component dental photocurable composition>
[0210] All the ingredients except the filler (E) shown in Table 2 were put into a wide-mouth plastic container, and mixed for 48 hours at 100 rpm using a mixing rotor VMRC-5 to obtain a matrix. Then, the matrix and the filler (E) were put into a kneader, and after uniform stirring, pastes 1 and 2 were obtained by degassing under vacuum, and then pastes 1 and 2 were filled into a double syringe (5 mL) made by a mixing packaging company (Mikspark) to prepare a dental photocurable composition. For a two-component dental photocurable composition, a paste 1 and 2 were mixed using a mixing tip made by a mixing packaging company. The mixing tip made by the mixing packaging company is a static mixer. When using it, paste 1 and paste 2 can be kneaded in a volume ratio of 0.9 to 1.1: 1.0. When converted to a mass ratio, paste 1 and paste 2 are kneaded into 0.8 to 1.2: 1.0 for use. It should be noted that in Table 2, the mass parts of each component are recorded in brackets after the abbreviations of each component.
[0211] Table 2
[0212]
[0213] <Accelerated test conditions>
[0214] The one-component dental photocurable composition and the two-component dental photocurable composition filled in each container were left to stand in a storage room set at 40° C. (Yamato Scientific Co., Ltd.) and a storage room set at −5° C. (KGT-4010HC, Nippon Freeze Co., Ltd.) and stored for 6 months.
[0215] <Evaluation 1: Confirmation of appearance>
[0216] After taking out the single-component dental photocurable composition and the two-component dental photocurable composition stored at -5°C from the storage room, they were left to stand at room temperature of 15 to 25°C for 1 week, and 1 g of the paste was discharged from the container. At this time, if no precipitate was visually confirmed, it was judged as A: good; if more than 1 and less than 5 precipitates were confirmed, it was judged as B: within the allowable range; if more than 5 precipitates were confirmed, it was judged as C: there was a problem with the appearance.
[0217] <Evaluation 2: Confirmation of storage stability by bending strength>
[0218] After filling the dental photocurable composition into a stainless steel mold, cover glasses are placed on both sides, and after being pressed with a glass mixing plate, a photopolymerization irradiator (pen bright: made by Songfeng) is used to irradiate light for 10 seconds at each of 5 locations to cure it. After curing, after removing the cured product from the mold, the back side is also irradiated with light again in the same way, and it is used as a test sample (25×2×2mm: rectangular shape). After the test sample is immersed in 37°C water for 24 hours, a bending test is performed. For a two-component photocurable composition, a bending test is performed within 1 hour after light irradiation. The bending test is performed using an Instron universal testing machine (made by Instron Corporation) under the conditions of a distance of 20mm between the fulcrums and a crosshead speed of 1mm / min. The storage stability is evaluated using (Formula 2) based on the results of the bending test. If the change is greater than -5% compared to before storage, it has high storage stability. If the change is between -5% and -15%, the storage stability is slightly poor. If it is a value lower than -15%, it is judged that the storage stability is significantly poor.
[0219] (Flexural strength after storage (MPa) - Flexural strength before storage (MPa)) / (Flexural strength before storage (MPa)) × 100 [%] (Formula 2)
[0220] Furthermore, the flexural strength before the accelerated test is evaluated. For the flexural strength of a one-component photocurable composition and a two-component photocurable composition containing 100 parts by mass or more of (E) filler relative to 100 parts by mass of the polymerizable monomer, a value greater than 100 MPa is judged to be good, 80 to 100 MPa is judged to be applicable, and a value less than 80 MPa is judged to be insufficient. For the flexural strength of a one-component photocurable composition and a two-component photocurable composition containing less than 100 parts by mass of (E) filler relative to 100 parts by mass of the polymerizable monomer, a value greater than 90 MPa is judged to be good, 60 to 90 MPa is judged to be applicable, and a value less than 60 MPa is judged to be insufficient. The flexural strength varies depending on the amount of filler, so different benchmarks are set.
[0221] <Evaluation 3: Ambient light stability>
[0222] Use a photometer to adjust the height of a dental lamp (Luna-Vue S, manufactured by Morita Manufacturing Co., Ltd.) so that light with an illumination of 8000±1000lx is irradiated to the sample setting part. After placing a slide glass (26×16mm, 2mm thick) on a glass mixing plate covered with matte black paper, about 30mg of sample is taken thereon. After exposing the sample to the sample setting part for 60±5 seconds, take out the sample from the sample setting part, and immediately press other slide glasses on the sample to form a thin layer. If the state of the sample at this time does not maintain a physically uniform state, it is judged that curing has begun, and the time until curing is evaluated in units of 5 seconds. The longer the time, the better the ambient light stability. For ambient light stability, more than 90 seconds will be judged as good, more than 60 seconds to less than 90 seconds will be judged as applicable, and less than 60 seconds will be judged as insufficient. Ambient light stability refers to the time during which the dental light-curable composition is discharged from the container and can fully change its shape without being cured by ambient light such as fluorescent light until adaptation. Since the space in the oral cavity is small, the operation is inconvenient, and the shape of each person's natural teeth is very complicated, the longer the ambient light stability is, the more preferable it is to adapt to various cases.
[0223] <Evaluation 4: Light color stability>
[0224] After filling the prepared dental photocurable composition into a stainless steel mold (15φ×1mm: disc-shaped), a cover glass was placed from the top and pressed with a glass plate. The cover glass was irradiated with light for 1 minute using a photopolymerization irradiator (Griplight II: made by Matsukaze) to cure it. After taking out the cured product from the mold, the cover glass was removed and the color tone of the test sample was measured. The test sample was placed on a background of a standard white plate (D65 / 10°X=81.07, Y=86.15, Z=93.38) and color was measured using a spectrocolorimeter (made by BYK Chemical) under specified conditions (light source: C, viewing angle: 2°, measurement area: 11mm). Then, the test sample was exposed to light for 24 hours using a xenon light exposure tester (Suntest CPS+), and the color tone of the test sample was measured again. The difference in color change was expressed by ΔE calculated by the following formula.
[0225] ΔE={(ΔL*) 2 +(Δa*) 2 +(Δb*) 2} 1 / 2
[0226] ΔL*=L1*-L2*
[0227] Δa*=a1*-a2*
[0228] Δb*=b1*-b2*
[0229] Among them, L1* is the brightness index before light exposure, L2* is the brightness index after light exposure, a1 and b1* are the color quality indexes before light exposure, and a2* and b2* are the color quality indexes after light exposure. The case where ΔE is less than 5 is judged to be the best, the case where ΔE is 5 to 10 is judged to be good, and the case where ΔE is greater than 10 is judged to be applicable. When the light color stability is good, there is little discoloration during use and high aesthetics can be maintained.
[0230] <Evaluation 5: Thermal color stability>
[0231] After filling the prepared dental photocurable composition into a stainless steel mold (15φ×1mm: disc-shaped), a cover glass is placed from the top and pressed with a glass plate. The cover glass is irradiated with light for 1 minute using a photopolymerization irradiator (Griplight II: made by Matsukaze) to cure it. After removing the cured product from the mold, the cover glass is removed and the color tone of the test sample is measured. The test sample is placed on a background of a standard white plate (D65 / 10°X=81.07, Y=86.15, Z=93.38) and the color is measured using a spectrophotometer (made by BYK Chemical) under specified conditions (light source: C, viewing angle: 2°, measurement area: 11mm). Then, in a thermostat set at 70°C, the test sample is immersed in a container containing 10mL of water, and after standing for one week, the color tone of the test sample is measured again, and the difference in color change is expressed by ΔE calculated by the following formula.
[0232] ΔE={(ΔL*) 2 +(Δa*) 2 +(Δb*) 2} 1 / 2
[0233] ΔL*=L1*-L2*
[0234] Δa*=a1*-a2*
[0235] Δb*=b1*-b2*
[0236] Among them, L1* is the brightness index before immersion / standing, L2* is the brightness index after immersion / standing, a1 and b1* are the color quality indexes before immersion / standing, and a2* and b2* are the color quality indexes after immersion / standing. A, the case where ΔE is less than 5 is judged as the best; the case where ΔE is 5 to 10 is judged as good; the case where ΔE is greater than 10 is judged as applicable. In the case of good thermal stability, there is little discoloration when the dental material is used in the oral cavity for a long time, and a high aesthetic state can be maintained for a long time.
[0237] The results of each test shown in Tables 3 and 4 are described.
[0238] Table 3
[0239]
[0240] Table 4
[0241]
[0242] It was confirmed that the composition described in the examples exhibited a flexural strength of 80 MPa or more at the preparation stage, and that the flexural strength did not significantly decrease even when stored for a long period of time under low temperature conditions.
[0243] For Examples A8, A9, A15, A16, A23, B8, B9, B15, B16, and B17, the bending strength showed a slightly low value due to the slightly small amount of the photoacid generator. On the other hand, when the amount of the photoacid generator was slightly large, as in Examples A12, A13, A14, and B14, the bending strength tended to decrease when the storage test was performed at a high temperature of 40°C, and the ambient light stability became shorter and the light color stability decreased. When the photoacid generator contains C8 and C9, which are salts of anions and iodonium cations with logS of -4 to -5, there is no problem with low-temperature storage when the amount is small, as in Examples A8, A9, B8, and B9. The storage stability of Examples A10, A11, B10, and B11, which have increased amounts, and Examples A12, A13, B12, and B13, which have further increased amounts, tends to be slightly reduced. Some precipitates are confirmed during low-temperature storage, and there is a tendency for the light color stability to be slightly poor, but this is a change within the range that can be used without problems. In addition, it is confirmed that even if a salt of anions and iodonium cations with logS greater than -4, i.e., an iodonium salt compound, is included, if it is a trace amount of about 0.1 parts by mass relative to 100 parts by mass of the polymerizable monomer, it will not have a significant effect on the storage stability.
[0244] It was confirmed that the bending strength of Examples A22 and B22 tended to decrease due to the slightly small amount of photosensitizer, and that although the bending strength of Examples A21, A47, and B21 was high due to the slightly large amount of photosensitizer, the ambient light stability and the light color stability tended to decrease. In addition, compared with the composition containing an α-diketone compound as the photosensitizer, Examples A36 and B36 containing acylphosphine oxide, i.e., BAPO, tended to decrease in bending strength.
[0245] It was confirmed that Examples A18, A48, and B18 tend to have low bending strength due to a slightly small amount of photopolymerization accelerator, and that Examples A19, A20, and B20 tend to have low ambient light stability and low light color stability although they have high bending strength due to a slightly large amount of photopolymerization accelerator.
[0246] Examples A26, A27, B26, and B27 contain dibenzylaminoethanol (DBAE) having one primary hydroxyl group as a photopolymerization accelerator, Examples A28 and B28 contain methyldiethanolamine having two primary hydroxyl groups as a photopolymerization accelerator, and Examples A29 and B29 contain triethanolamine having three primary hydroxyl groups as a photopolymerization accelerator. Comparison of these results shows that the thermal color stability tends to decrease as the number of primary hydroxyl groups increases, and in particular, the thermal color stability decreases significantly when two or more primary hydroxyl groups are present.
[0247] Examples A30, A31, A32, B30, B31, and B32 contain DMBE, which is an aromatic amine, as a photopolymerization accelerator. It was confirmed that when an aromatic amine is contained, the light color stability is reduced. On the other hand, in the case of a composition containing an aromatic amine and a UV absorber as in Examples A33, A34, B33, and B34, the light color stability can be prevented from being reduced. However, since the UV absorber increases the yellow color of the cured body, it itself does not contribute to improving the physical properties, and therefore sometimes a large amount of addition may cause a decrease in mechanical strength, so it is more preferably not added.
[0248] Examples B41, B42, B44, and B45 contain aromatic amines as chemical polymerization accelerators, and similarly to those containing aromatic amines as photopolymerization accelerators, the light color stability tends to decrease. In addition, Examples B42, B44, and B45 containing aromatic amines having two primary hydroxyl groups in the molecule such as DEPT also tend to have a decreased thermal color stability.
[0249] Comparative Examples CA1 and CB1 do not cure or have significantly reduced flexural strength because they do not contain a photosensitizer. Comparative Examples CA2 and CB3 have significantly reduced flexural strength because they do not contain a photoacid generator. Comparative Examples CA3 and CB2 have significantly reduced flexural strength because they do not contain a photopolymerization catalyst. Comparative Examples CA4 to CA13 and CB4 to CB13 contain anions with a logS greater than -4 and iodonium cations, i.e., iodonium salt compounds. Although it has not been confirmed that the storage stability of Comparative Examples CA4, CA5, CB5, and CB6, which have a small amount of photoacid generator, is reduced, their flexural strength is insufficient. As in Comparative Examples CA6 to CA9 and Comparative Examples CB6 to CB9, when the amount of photoacid generator is increased, although the flexural strength is improved, precipitates are confirmed when stored at low temperatures, confirming that there is a tendency for the flexural strength to decrease. In addition, it has been confirmed that the light color stability is reduced. In addition, it was confirmed that although the bending strength of Comparative Examples CA10 to CA13 and Comparative Examples CB10 to CB13, which had an increased amount of the photoacid generator, was further improved, the storage stability during low temperature storage and high temperature storage was reduced and the photocolor stability was reduced. The solubility of the photoacid generator affects the storage stability and color stability.
[0250] The dental photocurable composition of the present invention evaluated by the examples can be used for any known dental photocurable composition without any problem. The dental photocurable composition is a dental adhesive material, a dental composite resin, a dental abutment repair material, a dental resin cement, a dental coating material, a dental pit and fissure sealing material, a dental cosmetic material, a dental loose tooth fixing adhesive material, a dental glass ionomer cement, a dental hard resin, a dental cutting material, a dental 3D printing material, etc.
[0251] In this specification, when a constituent element of the invention is described as being in the singular or plural, or when described without limitation to the singular or plural, the constituent element may be in the singular or plural unless otherwise understood from the context.
[0252] Although the present invention has been described with reference to detailed embodiments, it will be understood by those skilled in the art that various changes or modifications may be made based on the matters disclosed in this specification. Therefore, it is intended that the scope of the embodiments of the present invention includes any changes or modifications.
[0253] According to the present invention, it is possible to provide a dental photocurable composition that exhibits excellent mechanical properties even after returning from low temperature to room temperature.
Claims
1. A dental photocurable composition, wherein: The dental photocurable composition comprises (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator. Furthermore, the photoacid generator (C) comprises an iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less calculated using the chemical drawing professional software ChemDraw, The iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less calculated using the chemical drawing professional software ChemDraw is contained in an amount of 0.5 to 10 parts by mass relative to 100 parts by mass of the polymerizable monomer (A); The (D) photopolymerization accelerator is selected from primary to tertiary amine compounds of aromatic amine compounds, primary to tertiary amine compounds of aliphatic amine compounds, and organic metal compounds.
2. The dental photocurable composition according to claim 1, wherein The iodonium salt compound formed by (C-1) and an anion whose logS is -4 or less calculated using the chemical drawing professional software ChemDraw includes an aryl iodonium salt composed of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga, and an aryl iodonium cation.
3. The dental photocurable composition according to claim 1, wherein The iodonium salt compound formed by (C-1) and an anion whose logS is -4 or less calculated using the chemical drawing professional software ChemDraw includes an aryl iodonium salt composed of an anion having an organic group in which at least one H is substituted by F and one or more atoms of P, B, Al, S, and Ga, and an aryl iodonium cation.
4. The dental photocurable composition according to claim 1, wherein (D) The photopolymerization accelerator contains an aliphatic tertiary amine compound.
5. The dental photocurable composition according to claim 1, wherein (D) The photopolymerization accelerator contains (D-1) an aliphatic tertiary amine compound not having two or more primary hydroxyl groups.
6. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition is a single-component dental photocurable composition. The (B) photosensitizer is contained in an amount of 0.005 to 1.0 parts by mass, the (C) photoacid generator is contained in an amount of 0.5 to 10.0 parts by mass, and the (D) photopolymerization accelerator is contained in an amount of 0.01 to 20 parts by mass, based on 100 parts by mass of the (A) polymerizable monomer.
7. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition is a two-component dental photocurable composition. It is composed of a first paste and a second paste. The ratio of the first paste to the second paste is 1:0.8~1.
2. The first paste and the second paste contain 0.01 to 2.0 parts by mass of a (B) photosensitizer, 1.0 to 20 parts by mass of a (C) photoacid generator, and 0.02 to 40 parts by mass of a (D) photopolymerization accelerator, based on 200 parts by mass of the total (A) polymerizable monomer contained in the first paste and the second paste.
8. The dental photocurable composition according to any one of claims 1 to 5, wherein (A) The polymerizable monomer includes an acidic group-containing polymerizable monomer.
9. The dental photocurable composition according to claim 8, wherein The amount of the acidic group-containing polymerizable monomer to be added is 1 part by mass or more based on 100 parts by mass of the total amount of polymerizable monomers contained in the dental photocurable composition.
10. The dental photocurable composition according to claim 8, wherein The amount of the acidic group-containing polymerizable monomer to be added is 10 parts by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
11. The dental photocurable composition according to any one of claims 1 to 5, wherein (A) A silane coupling agent is contained as a polymerizable monomer.
12. The dental photocurable composition according to claim 11, wherein The amount of the silane coupling agent added is 1 part by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
13. The dental photocurable composition according to claim 11, wherein The amount of the silane coupling agent is 10 parts by mass or more and less than 20 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
14. The dental photocurable composition according to any one of claims 1 to 5, wherein (A) The polymerizable monomer includes a polymerizable monomer having a sulfur atom.
15. The dental photocurable composition according to claim 14, wherein The amount of the polymerizable monomer having a sulfur atom is 0.01 parts by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
16. The dental photocurable composition according to claim 14, wherein The amount of the polymerizable monomer having a sulfur atom is 0.1 parts by mass or more and less than 10 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.
17. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photosensitizer (B) is 0.005 to 1.0 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
18. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photosensitizer (B) is 0.05 to 1.0 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
19. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less calculated using the chemical drawing professional software ChemDraw is 1.0 part by mass or more relative to 100 parts by mass of the total amount of the (A) polymerizable monomer contained in the dental photocurable composition.
20. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less calculated using the chemical drawing professional software ChemDraw is 5 parts by mass or less relative to 100 parts by mass of the total amount of the (A) polymerizable monomer contained in the dental photocurable composition.
21. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less calculated using the chemical drawing professional software ChemDraw is 1.0-5.0 parts by mass relative to 100 parts by mass of the total amount of the (A) polymerizable monomer contained in the dental photocurable composition.
22. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photoacid generator (C) is 0.5 to 10.0 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
23. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photoacid generator (C) is 1.0 to 5.0 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
24. The dental photocurable composition according to any one of claims 1 to 5, wherein The photoacid generator (C) contains only an iodonium salt compound formed by (C-1) and an anion having a logS of -4 or less calculated using the chemical drawing software ChemDraw.
25. The dental photocurable composition according to any one of claims 1 to 5, wherein (C) The photoacid generator contains only a salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga as an aryliodonium salt and an aryliodonium cation.
26. The dental photocurable composition according to any one of claims 1 to 5, wherein (C) The photoacid generator includes a salt of an anion of an organic group having at least one H group replaced by F and at least one atom of P, B, Al, S, and Ga, and an aryliodonium cation.
27. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photopolymerization accelerator (D) is 0.01 to 20 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
28. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photopolymerization accelerator (D) is 0.1 to 10 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
29. The dental photocurable composition according to any one of claims 1 to 5, wherein (D) The photopolymerization accelerator contains only aliphatic tertiary amine compounds.
30. The dental photocurable composition according to any one of claims 1 to 5, wherein (D) The photopolymerization accelerator contains only (D-1) an aliphatic tertiary amine compound not having two or more primary hydroxyl groups.
31. The dental photocurable composition according to any one of claims 1 to 5, wherein (D) The photopolymerization accelerator contains only aliphatic tertiary amine compounds having no primary hydroxyl group in the molecule.
32. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition includes (E) a filler.
33. The dental photocurable composition according to claim 32, wherein The blending amount of the filler (E) is 10 to 1000 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
34. The dental photocurable composition according to claim 32, wherein The amount of the filler (E) is less than 500 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A) contained in the dental photocurable composition.
35. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition includes a chemical polymerization initiator.
36. The dental photocurable composition according to claim 35, wherein Chemical polymerization initiators are organic peroxides.
37. The dental photocurable composition according to claim 35, wherein The amount of the chemical polymerization initiator is 0.1 to 5 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomers.
38. The dental photocurable composition according to claim 35, wherein The amount of the chemical polymerization initiator is 0.3 to 3 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomers.
39. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition includes a chemical polymerization accelerator.
40. The dental photocurable composition according to claim 39, wherein The chemical polymerization accelerator is one or more selected from the group consisting of 4th period transition metal compounds, thiourea derivatives, aliphatic amines, aromatic amines, sulfinic acid and its salts, borate compounds, sulfur-containing reducing inorganic compounds, nitrogen-containing reducing inorganic compounds, barbituric acid derivatives, triazine compounds, and halogen compounds.
41. The dental photocurable composition according to claim 39, wherein The amount of the chemical polymerization accelerator to be added is 0.01 to 5 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomer.
42. The dental photocurable composition according to claim 39, wherein The amount of the chemical polymerization accelerator to be added is 0.1 to 3 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomers.
43. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition further comprises one or more selected from a UV absorber, a polymerization inhibitor, a chain transfer agent, a metal scavenger, a discoloration inhibitor, an antibacterial agent, and a coloring pigment.
Citation Information
Patent Citations
Photopolymerization initiator and photocurable composition
CN108697586A
Photopolymerizable dental compositions
CN1295455A
Photosensitive composition
EP3398975A1
Photosetting composite restoration material for dental use
JP2005213231A
Liquid, hybrid UV / vis radiation curable resin compositions for additive fabrication
US20170355857A1
